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ABSTRACT
RNA SYNTHESIS AND HISTONE ACETYLATION 
IN THE RAT HEART DURING 
NATURAL HYPERTROPHIC GROWTH
by
James Donald McCully 
RNA synthesis and histone acétylation in the rat heart 
were examined using the natural growth model for cardiac 
hypertrophy. Cardiac tissue weight increased seven fold 
(p< ,01) from 21 to 100 days of age. RNA and DNA content 
increased (p< .01) during this period however RNA content in 
relation to DNA content decreased (p < .01) indicating that 
possibly the synthesis of RNA in relation to DNA is reduced 
with age. In order to determine the rate of RNA synthesis in 
the naturally hypertrophying heart,isolated hearts from animals 
aged 21, 50, and 10 0 days of age were perfused with^j^]^ 
uridine (0.1 uCi/ml;51.0 Ci/mmol.). RNA synthesis corrected 
for alterations in the specific activity of the cytoplasmic 
uridine nucleotide pool decreased five fold from 21 to 50 
days of age (p< .01) and four fold from 21 to 100 days of 
age (p< .01). Total nuclear RNA polymerase activity decreased 
two fold (p< .01) from 21 to 10 0 days of age. No difference
IV
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in total RNA polymerase activity was found between 50 and 
100 days of age. There was no difference in myocyte enzyme 
activity from 21 to 10 0 days of age. Non-myocyte nuclear 
RNA polymerase activity was three fold greater (p< ,01) 
than myocyte enzyme activity at 21 days of age, while 
myocyte RNA polymerase activity was two fold greater (p< .01) 
than non-myocyte activity at 100 days of age. No difference 
between myocyte and non-myocyte enzyme activity was found at 
50 days of age. Increased histone acétylation and RNA synthesis 
were not coincidental in this model; however, histone 
acétylation increased with age. In addition the percentage 
composition of core histones H3 and H2a+2b in myocyte and 
non-myocyte nuclei was altered during natural cardiac enlarge­
ment. It would appear that RNA synthesis in the naturally 
hypertrophying heart is coordinated with DNA-template 
availabilty and RNA polymerase activity; however, the relative 
contribution of histone acétylation and enzyme activity 
varies with age.
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CHAPTER I
INTRODUCTION
A fundamental adaptive mechanism of the heart,is the 
development of cardiac hypertrophy, in response to an in­
creased workload. The physiological mechanism(s), however, 
that permit the heart to increase its size without the 
development of new muscle cells remains unresolved.
Several studies have used chronic and severe exercise 
regimens in order to provide a stimulus for cardiac hyper­
trophy (Bloor and Leon, 1970; Dowell et al., 1976; Tibbet 
et al., 1978; Carrey et al», 1979 ; Hickson et al., 1979 ; 
Schaible and Scheuer, 1979). These training programmes re­
quire protocols of eight to twelve weeks of daily exercise 
in order to induce a modest (12-15%) degree of hypertrophy 
(Dowell et al., 1976; Tibbits et al., 1978; Hickson et al., 
1979) . An alternate method to study the mechanisms of 
physiological cardiac hypertrophy is the use of the 
natural growth model (Geary and Florini, 1972).
It has been previously reported that there exists a 
six fold increase in cardiac tissue weight in rats from 
birth to adulthood (Korecky et al., 1979).
Autoradiographic and histological studies have shown that 
mitosis occurs in cardiac myocytes only within the first
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
two to three weeks of postnatal development, and that the 
temporal increase in tissue weight following this period is 
the result of myocyte hypertrophy and not by hyperplasia 
of individual muscle cells (Bishop, 19 71; Neffgen and 
Korecky, 1972; Zak, 1974; Bugaisky and Zak, 1979; Claycomb, 
1979 ; Cutilletta, 1979).
Several studies have examined the alterations in DNA, 
RNA, and protein content during cardiac hypertrophy and 
have reported significant increases in protein/DNA (Fanburg 
and Posner, 1968; Grove et al., 19 69a; Grove et al.,
1969b), RNA/DNA ratios (Nair et al., 1968; Koide and 
Rabinowitz, 19 69), and the rate of RNA synthesis (Beznak et 
al., 1973; Meerson et al., 19 78).
Since RNA is essential for protein synthesis and appears 
to increase in various forms of induced cardiac hypertrophy 
one mechanism regulating cardiac growth may be related to 
factors that directly alter the synthesis of RNA. One 
possible site of control may be the proteins associated 
with the DNA. This hypothesis has been supported by the 
work of Pogo et al., 1968, and Allfrey, 1968, who suggest 
that a temporal relationship may exist between the basic 
proteins (histones) associated with the DNA and template 
activity in RNA synthesis. The close association of DNA 
bound proteins (histones and non-histones) suggests that 
these molecules may participate in the regulation of RNA 
synthesis. Evidence has accumulated indicating that
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
histones exhibit differential electrostatic binding to 
specific regions of DNA, and that those proteins that are 
tightly bound to DNA inhibit RNA synthesis in isolated 
nuclei (Allfrey, 1968; Marushige, 1976). Allfrey and 
Mirsky,(1963), have shown that the selective removal of 
nuclear histones resulted in a 300-400% stimulation of RNA 
synthesis, and that reconstitution of the histones resulted , 
in an immediate reduction in RNA synthesis.
A physiological mechanism that appears to influence 
histone binding is the enzymatically controlled acétylation 
of these proteins (Horiuchi and Fujimoto, 19 72; Horiuchi 
and Fujimoto, 1975; Taylor and Liew, 1976 ; Horiuchi et al., 
1978; Reeves et al., 1979; Fukishima et al., 1980;
Schewmaker and Wagner, 1980; Taylor and Cook, 19 81).
Increased histone acétylation weakens the electrostatic 
binding of histones to DNA so that more of the genetic 
material is available for RNA synthesis. Conversely, a 
reduced acétylation permits greater electrostatic 
interaction, so that more of the DNA is masked, diminishing 
template availability for RNA synthesis (Allfrey, 19 68; 
Marushige, 1976; Russanova et al., 1980).
Most of the information dealing with histone acétylation 
and RNA synthesis has been derived from regenerating liver, 
or cell culture systems, in which cells have a large 
capacity for mitosis (Nahora et al., 19 68; Ruiz-Carillo et 
al., 1975; Marushige, 1976; Jenson et al., 1980). Cardiac
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tissue, however, is a complex mixture of heterogenous 
components, consisting of terminally differentiated cardiac 
myocytes, and non-muslce cells (connective tissue, nerve 
cells, endothelial cells) which maintain the ability to 
regenerate (Grimm, 19 70; Claycomb, 1976; Bugaisky and Zak, 
1979; Cutilletta,. 1979) .
While earlier studies have indicated an increase in RNA 
synthesis, resulting from physiological, pharmacological, 
and surgical induced cardiac hypertrophy, these results may 
have been masked by the relative contribution of non-muscle 
cell nuclei, which account for 75% of the isolated nuclear 
population (Fanburg et al., 1968; Zak, 1974; Dowell et 
al., 1976; Bugaisky and Zak, 1979 ; Cutilletta, 1979).
Recent investigation in our laboratory, has shown that 
RNA synthesis, following a brief period of hypoxic 
stimulation, is specific to the cardiac myocyte (McDonald, 
1981). At present there is no direct information 
concerning muscle tissue indicating that increased histone 
acétylation is an obligatory mechanism for RNA synthesis, 
however, it has been suggested that the rate of 
transcription of the DNA template into RNA is governed by 
the availability of the template, and that the arrangement 
of histone and non-histone proteins around the DNA strands 
determines transcriptional activity (Cutilletta, 1979).
It was the purpose of this study to:
1) determine the rate of RNA synthesis in the myocardium;
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2) determine RNA polymerase activity in myocyte and 
non-myocyte nuclei;
3) determine the kinetics of histone acétylation;
4) specifically analyse histone composition in both 
myocyte and non-myocyte nuclei;and
5) to investigate histone acétylation in the naturally 
hypertrophying rat heart.
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CHAPTER II
METHODS AND MATERIALS
Experimental Model
Following the second to third week of postnatal develop­
ment in rats, cardiac muscle cell enlargement occurs by the 
hypertrophy of pre-existing myocytes, which have 
been shown to increase cellular volume five fold from birth 
to adulthood (Bishop, 1971; Zak, 1974; Claycomb, 19 75; 
Korecky and Rakusan, 1978; Bugaisky and Zak, 1979 ; 
Cutilletta, 1979; Korecky et al., 1979).
In order to determine the nuclear alterations inherent 
to amitotic tissue growth, three experimental age groups 
were used to provide a natural growth model for cardiac 
hypertrophy. Animals at 21 days (60 grams) were used to 
provide an early post mitotic phase, when cell volume was 
minimal. One hundred day old animals (600 grams) were used 
to provide a model for the late post-mitotic phase when 
cell volume was near the maximum. Fifty day animals (225 
grams) were used as a mid-point reference. It was 
hypothesized that this model would provide a sufficient 
cellular growth comparison to determine the temporal 
relationship between histone acétylation and RNA synthesis.
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Animal Care and Handling
Male, Wistar strain, rats, aged 21, 50, and 100 days, 
were purchased from Woodlyn Farms, Guelph, Ontario. All 
animals were housed individually and provided Purina Brand 
Laboratory Chow, and water ad libitum.
Method of Perfusion
All animals were anesthetized with sodium pentobarbital 
(Nembutal, 50 units/kg”^I.P). Following anesthetization, the 
abdominal cavity was opened with a ventral, mid-line in­
cision, the inferior vena cava located and 200 units of 
heparin injected, and allowed to circulate for 30 seconds.
The diaphragm was transected, and the heart rapidly removed 
and submerged in 0.14M saline solution (0-4^C) to arrest 
contractions. The heart was cannulated by the aorta, using 
fine tip forceps, on a modified Langendorff perfusion ap­
paratus (Morgan et al., 19 68; Taylor and Cerny, 1976), 
secured with a silk ligature, and perfused from a reservoir 
located 75 cm above the heart. The perfusion fluid (pH 
7.4) consisted of a Krebs-Henseleit bicarbonate buffer 
containing 15 mM glucose, and gassed with a 95% 0^: 5% CO^ 
gas mixture. The perfusate was maintained at 3 70c 
throughout the experimental period. Immediately following 
a 10 min preliminary perfusion to remove residual coronary 
blood, the cannulated hearts were transferred to a 
recirculating chamber and perfused with 30 ml of perfusate
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
containing either uridine (0.1 uCi*ml“3) oaPj^ Hj acetate
“ 1
(2.0 uCi'ml ). The first 5 ml of recirculating buffer was
collected and discarded to reduce tissue dilution of the
radio-label. The remaining 25 ml of perfusate was
recirculated for 60 min with h] uridine or 20 min witl^j^
acetate, at a constant perfusion pressure of 60 mm Hg.
Perfusion times were selected on the basis of previous
studies indicating that h] uridine incorporation was
sufficient following 60 min of perfusion at 60 mm Hg
(Taylor and Young 1981) and that maximal histone ^
acetate binding was achieved after 20 min of perfusion at
60 mm Hg (Taylor and Liew, 1976; Taylor and Cook, 1981).
Heart contraction rate was measured during the last 5 min
of perfusion at a perfusion pressure of 60 mm Hg.
Immediately following perfusion the hearts were rapidly
removed, quick frozen in liquid nitrogen, and stored at 
0
-20 C for subsequent biochemical analysis.
Samples of the radio-labelled perfusate buffer were 
taken prior to perfusion to ensure that the specific 
activity of the perfusate buffer was consistent for all 
samples. Post perfusion samples of the radio-labelled 
perfusate buffer were also taken to ensure that sufficient 
radio-labelled precursor was available for incorporation in 
the heart, during perfusion.
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\Perfusion of 21 day Hearts
Hearts from 21 day male, Wistar strain, rats were cannu- 
lated with a Yale 16 gauge needle. Special care was taken 
to dissect the pericardium before removal of the heart, in 
order to prevent aortic constriction resulting from peri­
cardial binding about the major vessels of the heart. In 
addition, it was found that the best method to cannulate 21 
day hearts was to locate the aorta while the heart was sub­
merged in ice cold 0.14 M saline, as the aortic walls would 
often adhere if they came into contact out of the saline 
solution. In this study the success rate for 21 day can- 
nulation increased progressively from 50% to 9 2.8%, with 
the majority of failures resulting from aortic splitting. 
With these modifications perfusion of 21 day hearts was 
the same as that of 50 and 10 0 day hearts.
Determination of Nucleic Acid Content
RNA and DNA content of the myocardium was determined by 
a modification of the method of Maggio et al., 1963 
(Cutilletta et al., 1975). Hearts (0.3-1.4 grams, wet 
weight) were submerged in 0.14 M saline solution (0-4^C) 
and allowed to thaw. The large vessels and atria were 
removed, the ventricles split, and the trimmed tissue was 
blotted dry on absorbent towelling, and weighed. The 
tissue was finely minced with scissors and homogenized with 
a Potter-Elvehjem tissue homogenizer in 4 ml of double 
distilled water. One ml aliquots were removed and added to
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4 ml of ice cold 0.5 N PCA and allowed to precipitate for 
15 rain, then centrifuged at 3K RPM for 15 minutes. The 
precipitate was washed once with 5 ml of 0.5 N PGA, twice 
with 95% ethanol and once with ether. The nucleic acids 
(RNA + DNA) were extracted from the washed nucleoprotein 
pellet twice with 3 ml each (1.5 ml was used for 21 day 
hearts, 0.3 grams, wet weight) of 0.5 N PGA for 30 min at 
80  ^G; stirring periodically is essential to facilitate 
hydrolysis of the nucleic acids. RNA content of the 
extract was determined by the orcinal method (Dische, 19 53) 
using yeast RNA (Sigma Biochemicals) as a standard. The 
DNA content was determined by the diphenylamine reaction, 
(Burton, 1956) using calf thymus DNA (Sigma Biochemical) as 
a standard.
Determination of Tissue Protein Gontent
A 1 ml aliquot from the homogenate was precipitated 
overnight on ice, with 10 ml of 10% TGA. The precipitate 
was washed with 2 ml of 5% TGA and centrifuged at 600 x g for 
10 min, then placed in boiling water with 2 ml of fresh 5% 
TGA. The precipitate was washed twice with 2 mleach of 5% 
TGA,, twice with chloroform; methanol: ether (2:1:1, 1:1:1, 
V:V), and once with ether. The washed precipitate was 
dissolved in IN NaOH (4 - 10 ml ,0.3 - 1.4 grams , wet 
weight) overnight at 40^G. Protein content was determined 
by the method of Lowry et al., 1951, using calf thymus 
histone (Sigma Biochemicals) as a standard.
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Determination of RNA Synthesis
The incorporation of^ ^  uridine into RNA was deter­
mined by transferring 500 ul of RNA extract to a counting 
vial with 10 ml of PCS liquid scintillation cocktail 
(^ersham Corporation) , and the radioactivity determined by 
liquid scintillation in a Beckman L 3150 P counter. All 
samples were determined in duplicate and their means 
recorded as one sample.
Extraction of Cytoplasmic Nucleotides
Cytoplasmic nucleotides were extracted by the method 
of Warner and Pinaraore,1967. Hearts (0.3 - 1.4 grams, 
wet weight), perfused with  ^ uridine (0.1 uCi*ml^ ), 
quick frozen in liquid nitrogen, and stored at -20^C, were 
allowed to thaw in 0.14 M saline solution (0-4^C). The 
large vessels and atria were removed and the ventricles 
opened. The trimmed tissue was blotted dry on absorbent 
towelling and weighed. The tissue was finely minced with 
scissors and homogenized with 3 ml of IN PCA with a 
Potter-Elvehjem tissue homogenizer (1 ml of IN PCA was used 
for 21 day hearts). The homogenate was centrifuged for 20 
min at 7K RPM, and the supernatant carefully removed and 
stored on ice. The pellet was resuspended in 0.5 volume, 
of the original extraction volume, with 0.5 N PCA, 
centrifuged, and the supernatants pooled. Nucleotide 
content was determined with a 1 ml sample, diluted 1:50 
with double distilled water, at 260 and 280 nm using a
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Beckman 25 spectrophotometer. The acid soluble fraction 
was neutralized by adding 10% more by volume of a washed IN 
alamine-freon solution, vortexed 3-4 min, and the pH of the 
upper fraction determined. A small volume of alamine- 
freon solution (0.1 - 0.2 ml) was added to acidic samples 
until the pH was greater than or equal to 7. The 
suspension was centrifuged at 3K rpm for 10 min, and the 
aqueous layer carefully removed and stored on ice. A 
second 1 ml sample, diluted 1:50 with double distilled 
water, was taken, nucleotide content determined 
spectrophotometrically at 260 and 280 nm, and percent 
recovery determined. Neutralized samples with less than 
9 0% recovery were re-extracted with 0.5 volume of double 
distilled water, vortexed, centrifuged, and the aqueous 
layer carefully removed and pooled with the previously 
extracted aqueous layer. All samples were stored at -70®C 
in a Revco Ultra-Low freezer, prior to analysis.
Determination of Cytoplasmic Uridine Nucleotide Pool
Cytoplasmic uridine nucleotide fractions were resolved 
by high pressure liquid chromatography (Beckman 334, 
Gradient Liquid Chromatograph) using an anion exchange 
column (Beckman Ultrasil Anion Exchange Column), coupled 
with a dual wavelength UV absorbance detector at 254 and 
280 nm. The neutralized acid soluble fractions were
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
13
resolved using a 30 min linear gradient (5-100%) of 1 M KH ^
PO"^ (HPLC grade) , pH 5.60, with a flow rate of 1 ml.miri*^ . 
(Morrison and Warner, 19 81).
Uridine nucleotide fractions were verified by the addition 
of purified nucleotides (Pabst Laüooratories) to the 
samples, and quantified by resolving a known concentration 
of each uridine nucleotide, and determining the area under 
each fraction.
The specific activity of the cytoplasmic uridine nucleo­
tide pools was determined by transferring a 500 ul aliquot 
of the total neutralized, acid soluble fraction to a 
counting vial with 10 ml of PCS liquid scintillation 
cocktail (Amersham Corporation) and the radioactivity 
determined by liquid scintillation in a Beckman LS 100 
counter. Under these conditions, UTP could not be 
resolved, and the specific radioactivity of the uridine 
nucleotide pool was calculated as the sum of the resolved 
UDP and UMP fractions.
Isolation of Total Tissue Nuclei
Ventricular nuclei were isolated by the method of Jackowski 
and Liew 1980. All procedures were performed at 0-4®c.
Hearts (3.0 grams wet weight) previously quick frozen in 
liquid nitrogen and stored at -20 ^ C were allowed to thaw in 
0.14 M saline solution (0-4®C). The tissue was trimmed of 
large vessels and atria, the ventricles split, blotted dry 
on absorbent towelling and weighed. The tissue was finely
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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minced with scissors and homogenized in two volumes of 
solution A, containing 10 mM Tris HCl (pH 7,4), 0.24 M 
sucrose, 1 raM Mg C]g , 0.1 mM PMSF, 10 mM sodium butyrate, 
with a Potter-Elvehjem tissue homogenizer, and centrifuged 
at 1,000 X g for 10 minutes. The supernatant was discarded, 
and the pellet was homogenized in Solution A, and filtered 
through two layers of nylon mesh. The crude homogenate 
trapped in the mesh was carefully removed, rehomogenized in 
Solution A, refiltered and centrifuged at 1,000 g for 10 
minutes. The pellet was homogenized in Solution A 
containing 0.1% Triton XlOO, filtered through a metal sieve 
under vacuum, on ice, and centrifuged at 1,000 g for 10 
minutes. The pellet was allowed to dry by inversion for 10 
min, then homogenized in Solution C, containing 2.2 M 
sucrose, 10 mM Tris HCl (pH 7.4), 1 mM Mg Cl^ , 0.1 mM PMSF, 
10 mM sodium butyrate, carefully layered over 5 ml of 
Solution C, and centrifuged at 25K RPM for 60 min in a 
Beckman L Preparative Ultracentrifuge, using a Spinco SW 
25.1 rotor. The plug was removed and the crude nuclear 
pellet was drained and stirred with a glass rod. 
Fractionation of Total Tissue Nuclei
Isolated total tissue nuclei were fractionated into 
myocyte and non-myocyte nuclear fractions on the basis of 
their buoyant densities, using a discontinuous sucrose 
density gradient (Jackowski and Liew, 1980).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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In order to obtain a sufficient quantity of myocyte and 
non-myocyte nuclei, isolated total tissue nuclei from nine,
21 day hearts, (1.8 g total starting wet weight) were 
pooled. Fifty and 10 0 day myocyte and non-myocyte nuclear 
fractions were obtained by pooling the isolated total 
tissue nuclei from 3 isolations (3 g, starting wet weight, 
each). Single isolations using more than 3 g (wet weight) 
starting tissue are not recommended as the recovery of 
nuclei decreases as starting tissue weight is increased 
above 3 g (wet weight).
The pooled total tissue nuclear pellets were suspended 
in 4.3 ml of 2.0 M sucrose (55% w;w, in a stock solution 
containing 10 mM Tris HCl (pH 7.4), 10 mM Mg CI^  , 0.1 mM 
PMSF, 10 mM sodium butyrate), and carefully layered on a 
discontinuous sucrose density gradient consisting of 1.1 
ml, 2.7 M sucrose (69% w:w, in stock solution), and 1.1 ml 
of 2.3 M sucrose (61% w:w, in stock solution), and 
centrifuged at 25K RPM for 120 minutes.
Extraction of Myocyte and Non-Myocyte Histones
The myocyte nuclear pellet distributed across the 2.3 M, 
2.7 M sucrose interface was carefully transferred using a 
modified plastic Eppendorff tip, and stored on ice in 10 ml 
of Solution D (0.14 M NaCl, in stock solution) , for 10 
minutes. The non-myocyte nuclear pellet, located at the 
base of the centrifuge tube was suspended in 2 ml of 
Solution D and transferred in a similar manner. The
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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centrifuge tube was rinsed with 8 ml of Solution D, the
rinses pooled with the non-myocyte nuclear suspension,
allowed to stand on ice for 10 min, and centrifuged at
lOK RPM for 10 minutes. The pellet was resuspended in 2
ml of Solution D, allowed to stand on ice for 10 min, and
centrifuged at lOK RPM for 10 minutes. Nuclear histones
were extracted, stirring periodically, from the washed
nuclei, twice, with 1.5 ml, each of 0.25 N HCl, allowed to
stand on ice for 30 min and centrifuged at 12K RPM for
10 minutes. The supernatants were pooled, and the histones
precipitated overnight in 10 times volume of acetone, at
0-4 C. The precipitate was resuspended, centrifuged at
3K RPM for 20 min, and the supernatant carefully removed
by aspiration leaving approximately 5 ml in which the
pellet was resuspended, transferred to a conical test tube
and centrifuged at 3k RPM for 10 minutes. The pellet
was dried in vacuum for 60 min, then solubilized in 300 ul
of 0.01 N HCl with 15% sucrose for 60 min and centrifuged
at 3K RPM for 10 minutes. The supernatant was carefully
0
removed and stored at 0-4 C prior to fractionation (within 
12 hours) of histones. The pellet was stored for 
determination of nuclear DNA content.
Fractionation of Nuclear Histones
Nuclear histones were fractionated by the method as 
described by Panyim and Chalkey, 19 69, using acid urea 
poly-acrylamide gel electrophoresis. The gels were stained
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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overnight with amido black (0.1% in 7% acetic acid and 20% 
ethanol), and destained by diffusion with several changes 
in a 7% acetic acid, 20% ethanol solution.
Determination of Histone Fractions and Radioactivity
Specific histone fractions (HI, HI®, H3, H2A + 2B, H4) 
were determined by scanning the destained gels in a 
Gilford Densiometer at 620 nm, with an aperture of 0.5 x 
2.36. The maximum calibrated absorbance was 2.2 OD units 
using a scan rate of 2.0 cm.min^, and a chart speed of 5.0 
cm.min"^. The area under each fraction was determined by 
integration using a Numonics Graphics Calculator. Histone 
fractions were removed by slicing the gel with a sharp 
scalpel blade above and below the required histone 
fraction. To extract the histone protein from the gel 
slices each histone fraction was finely minced with 
scissors and transferred to a glass counting vial with 0.5 
ml of NCS tissue solubilizer,diluted with water 9:1,v:v, 
(Amersham Corporation) added. The vial was incubated at 
50 ^ C for 2 hours and allowed to cool. Ten ml of PCS II 
liquid scintillation cocktail (Amersham Corporation) was 
added, and the vials were placed in the dark for 24 
hours.
The radioactivity of each nuclear histone fraction 
was determined by liquid scintillation in a Beckman LSlOO 
counter.
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Determination of RNA Polymerase Activity
Myocyte and non-myocyte nuclei were isolated by the 
method as described by Jackowski and Liew, 1980. RNA 
polymerase activity was determined by the method of Nair et 
al., 19 68. Isolated nuclear fractions were suspended in
0.5 ml of incubation medium (5 mM PEP, 20 ug PK, 0.4 mM
3 -1
CTP, 0.4 mM ATP, 0.4 mM GTP, 0.024 mM H DTP (2.0 uCi.ml ;
43 Ci.mM"^), 50 mM Tris HCl (pH 7.5), 2.2 mM MnClg, 300 mM 
(NH^)^ SO^, adjusted to pH 7.5 with 1 M HCl), and incubated 
at 37® C for 15 minutes. Aliquots (100 ul) from incubated 
samples were spotted on 3 mm Whatman disc filters and 
allowed to absorb. The reaction was terminated by placing 
the filter discs in ice cold 10% TCA with 0.1 M 
pyrophosphate for 30 min, and washed in 1% TCA for 15 
minutes. The filter discs were washed with ethanol-ether 
(3:1) for 5 min, and ether for 5 minutes. Zero time blanks 
were washed separately to eliminate any possible con­
tamination due to washout during the TCA washes. The dried 
filter discs were placed in the bottom of a counting vial 
and 10 ml of PCS liquid scintillation cocktail (Amersham 
Corporation) added, and the radioactivity determined by 
liquid scintillation in a Beckman LS 100 counter. 
Statistical Analysis
A one way analysis of variance and Newman—Keuls post 
hoc analysis was used to test for statistical differences
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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between experimental groups. Statistically significant 
differences were acepted at p< .0 1.
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CHAPTER III
RESULTS
The Effect of Natural Cardiac Hypertophy on Heart Weight 
and Body Weight
The temporal increase in heart weight occurring from 21 
to 100 days of age, in the male, Wistar strain, rat, is il­
lustrated in figure lA. Heart weight increased, linearaly, 
from 0.28 grams at 21 days to 0.74 grams at 50 days, to 
1,4 3 grams at 100 days of age. This seven fold increase in 
heart weight was closely correlated with the 8.6 fold 
increase in body weight, illustrated in figure IB. Body 
weight increased from 60 grams at 21 days, to 223 grams at 
50 days, to 517 grams at 10 0 days of age.
These findings are similar to previously published norms, 
(Korecky and Rakustan, 1978; Woodlyn Laboratories, 1980).
Since nutritional variation and litter size have been shown 
to effect body weight and as a result heart weight (Korecky 
and Rakusan, 1978), these data suggest that the 
alterations in RNA synthesis and histone acétylation are 
not the result of either population or nutritional 
variance.
20
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Figure 1. The effect of natural cardiac hypertrophy 
on A) heart weight (mg) and B) body weight 
(mg). Values shown are means± SEM of 7-10 
animals.
21
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The Effect of Natural Cardiac Hypertrophy on Myocardial 
Nucleic Acid Content and Concentration
In order to determine if a natural growth model for 
cardiac hypertrophy was consistent with previously reported 
physiological, surgical, and pharmacological induced 
cardiac hypertrophy models, RNA and DNA content and 
concentration, as well as the ratio of RNA/DNA were 
analysed for each age group.
The concentration of total tissue RNA expressed in 
“• 3.mg.g (wet weight) is shown in figure 2B. RNA concentration
decreased significantly (p < .01) from 3.84*0.15 mg.^^ at
- 1  .1 
21 days, to 1,98±0.05 mg.g at 50 days, to 1.0+0.03 mg.g
at 100 days of age. However, if total tissue RNA content
is considered, and expressed mg per heart (figure 2A),
total RNA increases significantly (p < .01) from 1.05*0.05
mg.g^at 21 days, to 1.47± 0.06 mg.g^ at 50 days, to 1.70±
0.04 mg.g’  ^ at 100 days of age. While these findings would
appear contradictory, it must be noted that heart weight
increased 7 fold over this time period, and that while the
total tissue RNA content increased approximately 2 fold,
the relative increase in heart weight significantly
decreased RNA concentration.
A similar trend for tissue DNA concentration and 
total DNA content was observed. The DNA concentration, 
shown in figure 3B, and expressed as mg.g”  ^ (wet weight) 
decreased (p < .01) from 2.04*0.06 mg.g”^ at 21 days, to
23
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Figure 2. The effect of natural cardiac hypertrophy 
on A) total tissue RNA content (mg) and 
B) total tissue RNA cocentration (mg/gram) 
Values shown are meant SEM for 7-10 
animals.
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Figure 3. The effect of natural cardiac hypertrophy 
on A) total tissue DNA content (mg) and 
B) total tissue DNA concentration (mg/gram). 
Values shown are meant SEM for 7-10 
animals.
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1.28+0.03 mg.g^ at 50 days, to 0.83±0,02 mg,g at 100 
days of age. Total tissue DNA content expressed as mg per 
heart (figure 3A) increased (p < .01) from 0.57±0.02 mg at
21 days to 0.95±0.02 mg at 50 days, to 1,17±0.02 mg at 100 
days of age.
It has been previously reported (Claycomb, 19 76) that 
following the second to third week of postnatal develop­
ment, cardiac myocytes are terminally differentiated, and 
while karyokinesis may continue, there is no cytokinesis in 
the cardiac myocyte following this period. The two fold 
increase in DNA content may be attributed to increased 
non-myocyte DNA content, and not the result of myocyte cell 
proliferation.
The RNA/DNA ratio shown in figure 4, decreased (p<
.01) from 1.85:1 at 21 days, to 1.55:1 at 50 days, to 
1.45:1 at 100 days of age. This would indicate that while 
the total RNA and DNA content appears to increase 
approximately 2 fold from 21 to 100 days of age, total 
tissue RNA in relation to DNA decreases, and that possibly 
the synthesis of RNA in relation to DNA is reduced.
The Effect of Natural Cardiac Hypertrophy on Protein Content 
and Concentration and Nucleic Acids to Protein Ratios
Total myocardial protein (mg) shown in figure 5A in­
creased (p < .01) 8 fold from 21 days (9.26±0.27 mg) to 50
days (55.93± 3.38 mg) to 100 days of age (78.59- 3.25 mg).
2P
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Figure 4. The effect of natural cardiac hypertrophy 
on total tissue RNA/DNA ratio. Values 
shown are meaniSEM for 7-10 animals.
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Protein concentration expressed in mg.g (wet weight) and 
illustrated in figure 5B, increased (p < .01) from 21 days
(33.12+1.29 mg.g”^), to 50 days (75.3512.06 mg.g ^) but de­
creased (p < .01) at 100 days of age (53.2912.65 mg.g“^). 
This decrease in protein concentration has been previously 
attributed to increased connective tissue content in the 
hypertrophying heart, which may in part be supported by the 
increased total tissue protein content observed from 21 to 
100 days of age. This assumption, however, assumes a cons­
tant rate of protein synthesis and degradation during the 
process of hypertrophy.
To more clearly determine the alterations in nucleic 
acids which occur in the natural growth model for cardiac 
hypertrophy, RNA/protein (figure 6B) and DNA/protein (fig­
ure 6A) ratios were calculated. Both RNA/protein and DNA/ 
protein ratios decreased (p < .01) from 21 to 10 0 days of
age, and while similar trends were observed, the 
RNA/protein ratio decreased approximately 5 fold from 
0.11:1 at 21 days, to 0.03:1 at 50 days, to 0.02:1 at 100 
days of age, whereas the DNA/protein ratio decreased 3 fold 
from 0.06:1 at 21 days, to 0.021:1 at 50 and 100 days of 
age.
The alterations in total nuleic acids to protein ratios 
are clearly evident when the RNA+DNA/protein ratio is 
calculated. The total nucleic acids/protein ratio, shown 
in figure 7, significantly decreased (p < .01) from 0.12:1
31
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Figure 5. The effect of natural cardiac hypertrophy 
on total tissue A) protein content (mg) 
and B) protein concentration (mg/gram). 
Values shown are meaniSEM for 7-10 
animals.
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Figure 6 . The effect of natural cardiac hypertrophy 
on total tissue A) DNA/protein and B) 
RNA/protein. Values shown are means of 
7-10 animals.
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Figure 7, The effect of natural cardiac hypertrophy 
on total tissue nucleic acids (RNA+DNA)/ 
protein. Values shown are means of 7-10 
animals.
3G
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at 21 days, to 0.03:1 and 0.02:1 at 50 and 100 days 
respectively.
Collectively these data suggest that during this form of 
cardiac growth, the relative synthesis of nucleic acids was 
markedly reduced compared to protein synthesis in the 
heart, and that the temporal relationship between nucleic 
acid transcription and ribosomal translation may be altered 
with a g ^
The Effect of Natural Cardiac Hypertrophy on Myocardial 
Performance and Tissue Percent Water
Myocardial performance, measured as heart rate (BPM), 
recorded during the last five minutes of perfusion, and 
tissue percent water content, are shown in Tcible 1. No 
significant difference in either heart rate or tissue 
water content occurred following the perfusion of 21, 50 
and 100 day hearts. These data suggest that during the 
isolation and perfusion, the alterations occurring in the 
naturally hypertrophying heart from 21 to 100 days of age, 
are the results of specific temporal alterations in the 
myocardium, and not the result of tissue edema or 
hemodynamic failure."'
The Effect of Natural Cardiac Hypertrophy on Uridine 
Incorporation
In order to determine the kinetics of uridine in­
corporation in the naturally hypertrophying heart, hearts 
were perfused for one hour, with a Krebs-Henseleit
38
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 1. Myocardial performance and tissue percent 
water content. Values shown are means ± 
SEM for 7-10 animals.
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Table 1
Myocardial Performance and Tissue % Water 
Days of age HR (BPM) %H20
21 250+9
50 223+4
10 0 25 2+9
84.49+1.04 
86.31+0.25 
82.98+0.58
40
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bicarbonate buffer (pH 7.4) containing 15 mM glucose and 
 ^1^ hJ uridine (0.1 u Ci.ml"!) at 37^0 and at a constant 
perfusion pressure of 60 nun Hg (figure 8), A significant 
decrease (p < ,01) in  ^[^ hJ uridine occurred from 21 days 
(480+44 X 10"3 dpM) , to 50 days (9l±1.5 x 10"*^DPM) to 100 
days of age (72±8.5 x 10“3dpm). /This seven fold decrease 
in 3|^hJuridine incorporation, together with decreased 
nucleic acid concentration in the naturally hypertrophying 
heart, suggests that alterations in nucleosome 
transcriptional activity occur from 21 to 100 days of age 
and that these alterations may limit gene activation with 
age.
The Effect of Cardiac Hypertrophy on Cytoplasmic Uridine
Nucleotide Pools
In order to determine if alterations in uridine
nucleotide precursor pool size had an effect upon the
kinetics of RNA synthesis, as measured by ^ hJ uridine
incorporation, total cytoplasmic nucleotides were resolved,
by high pressure liquid chromatography (figure 9) at 21,
50, and 100 days of age. The specific activity of the
cytoplasmic uridine nucleotide pools, expressed as DPM.uM ^
is shown in figure 10, No significant difference in the
specific activity in the uridine nucleotide pool was found
between 21 (178+33 x 10 "^DPM.uM’l) and 50 days of age
(228+22 X 10 “^PM.uM "^ ) Î however, a significant decrease
“3
(p < ,01) was measured at 100 days of age (125±22 x 10
DPM.uM “ )^. The ratio of the specific activity of the
41
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Figure 8, The effect of natural cardiac hypertrophy 
on 3 ^ uridine incorporation. Values 
shown are meaniSEM of 7-10 animals.
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Figure 9. High pressure liquid chromatograph of
cytoplasmic uridine nucleotide pool.
44
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
a b s o r b a n c e  254 nm
o
o oto o-tN
o
en o00
-0
"D
m
O
u
3  Cn
*o
o
45
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 10. The effect of natural cardiac hypertrophy 
on the specific activity of cytoplasmic 
uridine nucleotide pool. Values shown 
are meaniSEM of four experiments.
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uridine nucleotide pools occurring at 50, and 100 days of 
age (1 :0 .55) was used to correct uridine incorporation data 
(DPM.mg'WA) .
The kinetics of RNA synthesis, in the naturally hyper- 
trophying heart, is shown in figure 11. A significant 
decrease (p < .01) in RNA synthesis ocurred from 21 days
(480,348 DPM.mg’^ RNA), to 50 days of age (90,878 DPM.mg"^
RNA), followed by a significant increase (p < .01) at 100 
days of age (131,491 D P M . m g R N A ) .’
The Effect of Natural Cardiac Hypertrophy on RNA Polymerase 
Activity in Isolated Myocyte and Non-Myocyte Nuclei
Cin order to determine if the decrease in RNA synthesis 
was related to alterations in RNA polymerase activity 
occurring from 21 to 100 days of age in the naturally 
hypertrophying heart, isolated nuclei were incubated for 
15 min with^ ^  h] UTP (2 uCi.ml’^; 4 3 Ci.mMole“ )^ and the 
enzymatic activity measured in p moles UMP incorporation.mg 
DNA”  ^ for 15 min incubation (Table 2). A significant 
increase (p < .01) in total RNA polymerase activity was
observed at 21 days of age with no significant difference 
between 50 and 100 days of age. (No significant difference 
in myocyte nuclei activity was found from 21 to 10 0 days of 
age, however, in the non-myocyte nuclei, RNA polymerase 
activity was found to be approximately 3 fold greater (p < 
.01) at 21 days than at 50 or 100 days of age, and 
significantly decreased (p < .01) from 50 to 100 days of age.
48
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Figure 11, The effect of natural cardiac hypertrophy 
on total tissue RNA synthesis. Uridine 
incorporation was corrected for alterations 
in the cytoplasmic uridine nucleotide pool.
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Table 2. PNA polymerase activity in isolated
myocyte and non-myocyte nuclei. Values
shown are meaniSEM of 7-10 animals.
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Table 2
RNA Polymerase Activity in Isolated Myocyte 
and Non-Myocyte Nuclei
Days of Age
RNA Polymerase Activity 21 50 10 0
Total Activity 2228+182 1092±41 1284+86
Myocyte Activity 616+141 516+18 853+99
Non-Myocyte Activity 1612+41 576±14 431±19
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(^Analysis of enzyme activity, between groups, revealed 
a significant elevation (p < .01) in non-myocyte RNA poly­
merase activity at 21 days, and in myocyte enzyme activity 
at 100 days of age. No significant difference between 
myocyte and non-myocyte RNA polymerase activity was found 
at 50 days of ageTy
■ These data would suggest that increased RNA polymerase 
activity was coincidental with increased RNA synthesis, and 
that RNA synthesis occurred primarily in non-myocytes, at 
21 days of age, and secondarily in the myocyte at 100 days 
of age^
Nuclear Histone Fractions; Nomenclature
Total myocyte and non-myocyte nuclear histones were 
fractionated under conditions designed to give maximum 
resolution. The five total nuclei histone bands from 21, 
50, and 100 day age groups are illustrated in figure 12. 
Arginine rich histone fractions, H3 and H4, from 21 day 
total tissue nuclei, exhibited histone subspecies which 
were not present in either 50, or 100 day age groups.
No nuclear-histone fraction subspecies 
were observed in any age group for either myocyte or non­
myocyte isolated nuclei (figures 13, 14, 15). Nuclear
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Figure 12. Densiometric scans of total tissue 
nuclear histones.
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Figure 13. Densiometric scans of 21 day myocyte
and non-myocyte nuclear histones.
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Figure 14. Densiometric scans of 50 day myocyte
and non-myocyte nuclear histones.
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Figure 15. Densiometric scans of 10 0 day myocyte
and non-myocyte nuclear histones.
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histone fraction was not present in the 21 day non­
myocyte nuclear fractions, however, it was present in the 
myocyte nuclear fraction. This observation is concurrent 
with previously reported data, indicating the coincidental 
occurrence of histone fraction Hl^ in non-dividing cells 
(Liew and Sole 19 78b), and indicates that the 21 day 
myocytes had terminally differentiated, and were, at this 
time point, enlarging by hypertrophy.
The Effect of Natural Cardiac Hypertrophy on Total Nuclear 
Histone Fractions
The percent distribution of histone fractions from 
total tissue nuclei is shown in Table 3. (^o significant
differences in total nuclear histone fractions HI, HlP ,H3, 
and H2A+2B occurred from 21 to 10 0 days of age, however, 
nuclear histone fraction H4 was significantly increased 
(p < .01) at 21 and 10 0 days of age.^
The Effect of Natural Cardiac Hypertrophy on Myocyte and 
Non-Myocyte Nuclear Fractions
Since total tissue nuclei is a complex mixture from 
many cell types, myocyte and non-myocyte nuclei were 
isolated and their histones extracted and fractionated on 
acid-urea poly-acrylamide gels^ (Table 4). Comparison of 
myocyte and non-myocyte histone fractions for each age 
group revealed distinct alterations in histone composition 
between groups , (Table 5). Nuclear histone fraction HI was 
consistently and quantitatively greater (p < .01) in the
62
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 3, Total nuclear histone percent distribution.
Values shown are mean±SEM of four experiments.
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Tab le 3
Total Nuclear Histone % Distribution
Histone
Fraction
21
Days of Age 
50 10 0
HI 22.57+0.97% 24.82+1.50% 20.40±0.96%
HIO 2.19+0.27 2.78±0.30 2.83+0.34
H3 20.70+1.51 16.24+1.44 16.89+1.11
H2A+2B 40.10+1.55 46.47+1.27 45.48+1.34
H4 14.43±1.64 9.69±1.40 14.40+0.73
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Table 4. Myocyte and non-myocyte nuclear histone
percent distribution. Values shown are
meaniSEM of four experiments.
65
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 4
Myocyte and Non-Myocyte Nuclear Histone % Distribution
Histone
Fraction
Myocyte
Hl
Hlo
H3
H2A+2B
H4
Non 
Hl 
Hlo 
H3
H2A+2B
H4
Myocyte
21
4.44±1.46
14.24±1.24
47.89±1.95
20.92+0.46
12.51±0.71
19 .22±1.82
25.42+1.68
44.98±0.83
13.42±0.25
Days of Age 
50
5.62±0.17 
30.00±0.82 
6.8 5±0.94 
51.11±1.20 
6,11±0.82
32.6 5±0.48 
4.74±0.27 
25.86±0.71 
32.35±1.63 
4.40+0.31
10 0
6.82±0.33
25.05±1.15
5.42±0.89
52.61±0.49
10.10±0.35
29.41±2.67 
4.75±0 .26
29.6 8±2.30 
26.10±2.50 
10.06+2.69
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non-myocyte nuclear fractions in all age groups studied;
0
however, the percent composition of the HI protein was 
significantly (p< .01) higher in the myocyte nuclear
fraction in 21, 50, and 100 day isolated nuclei. No 
difference was observed between the age groups in nuclear 
histone fraction H4 in either myocyte or non-myocyte 
nuclear fractions. Nuclear histone fraction H3 was 
significantly greater (p < .01) at 21 days in the myocyte
nuclear fraction than at 50 or 100 days of age, however, 
the non-myocyte H3 protein was significantly greater (p < 
.01) at 50 and 100 days, than at 21 days of age. This 
pattern was coincidental with increased (p < .01) myocyte
nuclear histone H2A+2B at 50 and 10 0 days of age, and in­
creased (p < .01) non-myocyte histone H2A+2B at 21 days of
age.
(^hese data suggest an overall pattern for 21, 50 and 
100 day nuclear histone percent composition, with no change 
in H4 composition, increased myocyte Hl^ and H2A+2B, and 
increased non-myocyte Hi and H3, but with quantitative 
reversal of H3 and H2A+2B occurring at 21 days of agè^ 
(Table 5).
Within group comparison revealed that non-myocyte 
histone fractions HI and HI 0, increased significantly 
(p < .01) from 21 to 10 0 days of age, with no significant
difference between 50 and 10 0 day fractions respectively. 
The arginine rich, non-myocyte nuclear histone fraction H3,
67
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Table 5* Myocyte and non-myocyte histone patterns 
X = increase.
- = no change.
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Table 5
Myocyte and Non-Myocyte Histone Patterns
Age
21 days
50 days
100 days
Nuclear
Fractions
Myocyte
Histones
HI Hlo H3 H2A+2B H4 
X X
Non-Myocyte X 
Myocyte
Non-Myocyte X 
Myocyte
Non-Myocyte X
X
X
X
X
X
X
X
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did not significantly differ from 21 to 100 days of age; 
however, the lysine rich H2A+2B, significantly decreased 
(p< .01) from 21 to 10 0 days of age. Non-myocyte nuclear 
histone H4 decreased significantly (p< .01) at 50 days
of age, with no difference occurring between 21 and 10 0 day 
age groups.
Myocyte nuclear histone fraction HI did not signifi­
cantly alter from 21 to 10 0 days of age, however, HI 0 and 
H2A+2B significantly increased at 50 and 10 0 days of age, 
with no significant differences occurring between these 
time points. Arginine rich myocyte nuclear histone 
fraction H3 significantly decreased (p<.01) from 21 
to 100 days of age, with no difference occurring between 50 
and 100 days of age. A significant decrease (p < .01) in
myocyte nuclear histone H4 occurred at 50 days, with no 
difference occurring at 21 or 100 days of age.
The Effect of Natural Cardiac Hypertrophy on  ^|^ H^  acetate 
Incorporation into Myocyte and Non-Myocyte Histone Fractions
To determine the effect of a natural growth model on 
covalent histone modification, hearts from 21, 50 and 100 day 
animals were perfused with acetate (2.0 uCi.ml ^ ) and
their nuclei isolated and fractionated into enriched popu­
lation of myocyte and non-myocyte nuclei^ (^uclear histones 
from each nuclear fraction were extracted and fractionated 
by acid urea polyacrylamide gel electrophoresis, and the
70
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radioactivity of each histone fraction determined by 
liquid scintillation.)
The incorporation of ^j^njacetate into myocyte nuclear 
histone fractions is shown in figure 16. The acétylation 
of myocyte nuclear histone fractions Hi and H3 
significantly increased (p< .01) from 21, to 50, to 100
days of age, with no significant difference occurring 
between 50 and 100 days of age. However in the non-myocyte 
nuclear histone fraction Hi® was not present at 21 days of 
age, and no significant difference in acétylation was found 
between 50 and 100 days of age. The acétylation of 
non-myocyte nuclear histone fraction H2A+2B was 
significantly less than (p < .01) at 21 days, than at 50 or 
100 days of age. Myocyte and non-myocyte nuclear histone 
H4 acétylation was significantly greater (p < .01) at 50
days, than at 100 days, which in turn was significantly 
greater (p < .01) than at 21 days, of age. No significant
difference in  ^|^hJ acetate incorporation for myocyte 
nuclear histone fraction HI®and H2A+2B, and non-myocyte 
nuclear histone fractions HI and H3, were found between 21 
and 100 days of age.
Crhese data suggest that RNA synthesis and histone acéty­
lation in the naturally hypertrophying heart are not co-
71
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Figure 16. The effect of natural cardiac hypertrophy 
on myocyte nuclear histone acétylation.
A  = 21 days.
O  = 50 days.
D  = 100 days.
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Figure 17, The effect of natural cardiac hypertrophy 
on non-myocyte nuclear histone acétylation.
A  =  21 d a y s .
O  = 50 days.
O  = 100 days.
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ordinated, and that while RNA polymerase activity is 
elevated in the non-myocyte nuclear fraction at 21 days and 
in the myocyte nuclear fraction at 100 days of age, no 
increase in histone acétylation occurs!')
The Effect of Natural Cardiac Hypertophy on Myocyte and Non- 
Myocyte DNA Content and Concentration
DNA content (mg) and concentration (mg.g"^ ) for myocyte 
and non-myocyte nuclear fractions is shown in Table 6. The 
percent recovery of DNA (mg.gram) from myocyte and 
non-myocyte nuclear fractions, compared to total tissue DNA 
extraction was approximately 21%,
7G
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Table 6. Myocyte and non-myocyte nuclear DNA 
content (rag) and concentration (mg/ 
gram). Values shown are meanlSEM of 
four experiments.
77
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Table 6
Myocyte and Non-Myocyte Nuclear DNA Content (mg) 
and Concentration (mg/gram)
Days of Age
Nuclear DNA 21 50 100
Total Myocyte (mg) 0,57±0.01 0.8 3±0.22 0.41+0.09
Total Non-myocyte (mg) 0.64+0.07 1.07±0.56 0.7 3+0.45
Myocyte (mg/gram) 0.19±0.01 0.12±0.05 0.07±0.01
Non-myocyte (mg/gram) 0.21±0.02 0.16±0.10 0.11±0.08
Percent Recovery 19.89 21.58 20.94
78
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7 0
CHAPTER IV
Discussion
yOne of the earliest events occuring during cardiac 
hypertrophy is an increased RNA content (Fanburg et al., 
1968; Grove et al., 1969a). This response suggests that 
cardiac enlargement may be regulated by factors which 
directly alter the synthesis of RNA.
Previously, cardiac hypertrophy has been investigated 
using surgical (Koide and Rabinowitz, 19 69 ; Florini and 
Dankberg, 1971), physiological (Hickson et al., 1979; 
Schaible and Scheuer, 1979) and pharmacological (Stanton et 
al., 1969 ; Wood et al., 1971; Lin, 1973; Yates and Dhalla, 
1975; Taylor et al., 1977) induced overloads to study the 
biochemical alterations occurring during cardiac 
enlargement. Although these biochemical responses may be 
variable and appear to be dependent upon the type, 
duration and intensity of the stimulus, these models have 
provided some important insights into this form of muscle 
tissue growth. Qcn order to eliminate response variation, 
and to provide some basic information about the normal 
growth of the heart, the natural hypertrophic model was 
selected.^
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The use of the natural growth model for cardiac hyper­
trophy (Wulff and Freshman, 1961; Geary and Florini, 1972; 
Meerson et al., 1978) provides a means to study the basic 
developmental processes of cardiac growth, which should pro­
vide a foundation to understand the responses of induced 
cardiac hypertrophyi
The enlargement of the cardiac tissue mass is funda­
mental to the process of cardiac hypertrophy. In the 
present study heart weight increased seven-fold from 21 to 
100 days of age, and was closely correlated with increased 
body weight. (These findings are similar to previously 
published norms (Korecky and Rakusan, 19 78) and indicate 
that cardiac enlargement in the naturally hypertrophying 
heart model was not the result of population or nutritional 
variance derived from alteration in either litter size or 
food intake.\
Increased cardiac tissue weight, while in agreement 
with previously reported investigations must reflect a 
highly coordinated series of complex cellular events that 
ultimately result in greater tissue mass. Previous in­
vestigations (Nair et al., 19 68; Grove et al., 19 69b) have 
reported a significant increase in nucleic acid content 
during an induced state of cardiac enlargement. In the 
naturally hypertrophying heart model total RNA and DNA con­
tent increased from 21 to 100 days of age. However, when 
these nucleic acids were analysed in relation to each
80
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other, (^ t was found that while both RNA and DNA content 
increased, the RNA content relative to DNA decreased with 
age, suggesting the possibility that RNA synthesis was 
restricted with age.)
Total myocardial protein increased from 21 to 10 0 days 
of age, as would be expected with a seven-fold increase in
heart weight. However, the concentration of protein (mg.
'*•1gram , wet weight) increased (p< .01) at 50 days of age
compared to the 21 day old hearts, followed by a marked re­
duction (p < .01) in protein concentration at 100 days of
age. Since previous reports have suggested that enhanced 
RNA synthesis probably precedes and accompanies an increase 
in protein synthesis (Rabinowitz et al., 19 70), (Jhese data 
would suggest that prior to 50 days of age RNA synthesis 
would be elevated while following this period RNA synthesis 
should be reduced? This hypothesis can in part be supported 
by the increase in the RNA/protein ratio occurring at 21 
days of age, but assumes that a constant rate of RNA synthe­
sis and degradation is present, and that no alterations 
occur during cardiac hypertrophy. The significant decrease 
in RNA/protein ratios at 50 and 10 0 days of age would also 
support this hypothesis. The decrease in RNA/protein, 
DNA/protein, and total nucleic acids/protein ratios from 
21 to 100 days of age indicate that the synthesis of nucleic 
acids responsible for protein synthesis possibly decreased 
with age, and suggest that the temporal relationship be-
81
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tween nuclear transcription and ribosomal translation may 
be altered with natural development. This latter hypothe­
sis is supported by Geary and Florini, (19 72) who reported 
that the rate of protein synthesis in the aging mouse heart 
is variable, and possibly represents a biological loss in 
the ability to synthesize heart proteins.
In order to determine directly if alterations in RNA 
synthesis occurred during natural cardiac hypertrophy 
hearts from 21, 50, and 100 day old animals were perfused 
with a Krebs-Henseleit bicarbonate buffer containing 15 mM 
glucose and uridine (0.1 uCi.ml” )^ at a constant per­
fusion pressure of 60 mm Hg. No difference in heart rate 
recorded during the last five minutes of perfusion or tissue 
percent water content was found to occur in these hearts 
from 21 to 100 days of age. (The stability of these measure­
ments indicate that during the isolation and perfusion, the 
alterations occurring in the naturally hypertrophying heart 
are the result of specific biochemical changes in the myo­
cardium and not the result of tissue edema or possible hemo­
dynamic failureT
The incorporation of uridine into RNA (DPM.mg RNA^ ) 
decreased seven-fold from 21 to 50 days of age with no 
change in incorporation occurring from 50 to 10 0 days of 
age. However, (^he possibility exists that the marked re­
duction in uridine incorporation may simply reflect:
R2
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(1) a dilution of the cytoplasmic nucleotide pool
(2) a reduction in the RNA polymerase enzymes
(3) or possibly, a combination of both.
When the incorporation of uridine was corrected
for the specific acitivty of the cytoplasmic uridine pool, 
the rate of RNA synthesis was found to be significantly 
elevated (p < .01) at 21 days of age. This increase was
approximately 5 fold greater than RNA synthesis occurring 
at 50 days of age and approximately 4 fold greater than 
100 days. vThese data agree with previously reported in­
vestigations (Meerson et al., 1978) and support the 
hypothesis that increased RNA synthesis is one of the 
earliest events occurring during cardiac hypertrophy and 
suggest that RNA synthesis precedes increased protein 
synthesis? The inverse relationshiip between RNA synthesis 
and protein concentration ( m g . g r a m , wet weight) suggest 
that possibly RNA synthesis need not necessarily accompany 
an increase in protein synthesis. These data would 
suggest that with aging, alterations in nuclear 
transcription may contribute to the loss in the ability of 
the heart to respond to stress or possibly replace heart 
proteins following tissue damagë\ (Geary and Florini, 19 72).
Recently, Cutilletta, 1979, has suggested that during 
the early phase of induced cardiac hypertrophy (1-3 days) 
the rate of transcription of the DNA template may be
p3
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
governed by; 1. the availability of the DNA template
2. the activity of RNA polymerase, or
3. some cooperative interaction between 
template availability and enzyme 
activity.
In this study RNA polymerase activity was measured 
under conditions in which the enzyme activity was not 
controlled by the DNA template. In this assay system the 
enzyme-chromatin complex was in a soluble state in which 
the nuclear proteins were removed from the DNA. The 
activity of the enzyme was not restricted by the chromatin 
structure, yet the DNA was intact and maximally available 
for transcription.
kTotal (myocyte and non-myocyte) RNA polymerase activity 
in isolated nuclei was found to be 2-fold greater (p < .01)
at 21 days than at 50 or 10 0 days of age. No significant 
difference in myocyte RNA polymerase activity was found 
from 21 to 10 0 days of age. However, non-myocyte RNA poly­
merase activity was found to be approximately 3-fold 
greater (p < .01) at 21 days than at 50 or 10 0 days of age.
In addition, non-myocyte RNA polymerase activity was 
significantly increased (p < .01) compared to myocyte
enzyme activity at 21 days of age while myocyte RNA 
polymerase activity at 10 0 days of age was significantly 
greater (p < .01) than non-myocyte enzyme activity.N No
difference between myocyte and non-myocyte enzyme activity
84
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was found at 50 days of age. These data would suggest that 
increased RNA polymerase activity is coincidental with 
increased RNA synthesis, and that RNA synthesis occurs 
primarily in non-myocytes, at 21 days of age, and in the 
myocyte at 100 days of age.'
Previous studies investigating RNA polymerase activity 
during surgically induced pressure overlaod have reported 
that enzyme activity was increased in the myocyte rather 
than the non-myocyte (Cutilletta et al., 1978). In the 
surgically induced model the myocardium must increase con­
tractility in order to overcome the pressure overload. In 
the naturally hypertrophying heart model no such long term 
stimulation appears to be present.
(This difference in RNA polymerase response would 
suggest that régulation of transcription in the myocardium 
may be altered, and supports the hypothesis that 
alterations in DNA transcription occurring during the 
process of cardiac enlargement may be an important 
mechanism in the regulation of myocardial hypertrophy 
(Liew and Sole, 1978a; Liew and Sole, 19 78b).
One mechanism proposed to regulate template activity 
is histone acétylation (Allfrey, 19 68; Taylor and and Liew, 
1976). (Histones are associated with nuclear DNA to form 
nucleosome structures consisting of 140 base pairs of DNA 
externally complexed with two each of the core histones 
H3, H2A, H2B, H4, and linked together with a spacer region
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of DNA containing histone Hi (Noll and Kornberg, 19 77)
(in regenerating cells studies, increased histone acéty­
lation has been shown to occur at the very early stages 
of RNA synthesis (Allfrey, 1968; Pogo et al., 1968). The 
enzymatically controlled acétylation of histones appears 
to weaken the electrostatic interaction of DNA with the 
histones and increase template availability for trans­
cription^ (Allfrey, 1968 ; Pogo et al., 19 68 ; Horuchi, 1978 ; 
Taylor and Cook, 1981).
In the natural growth model for cardiac hypertrophy, 
the acétylation of core histones revealed no distinct 
relationship to increased RNA synthesis for either néo­
cyte or non-myocyte nuclear fraction at 21 days of age. 
However, for 50 and 10 0 day hearts, the acétylation of 
myocyte histone fractions Hi, H3, and H4, and non-myocyte 
histone fractions Hi®, H2A+2B, and H4 were significantly 
increased (p < .01) compared to 21 days of age. These
data are consistent with previous investigations (Liew and 
Sole, 1978a; Liew and Sole, 1978b) which have reported in­
creased acétylation in the failing heart of cardiomyo- 
pathic Syrian hamsters.
Another possible mechanism for enhanced nucleosome 
activity may be the structural alteration of the nucleo­
some complex as reflected by the quantitative compositional 
change in the core histones. Quantitative analysis of 
myocyte and non-myocyte histone fractions revealed an
P6
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overall pattern for myocyte and non-myocyte nuclear histone 
composition, with increased myocyte histone Hl° and 
H2A+2B, and increased non-myocyte HI and H3 occurring at 50 
and 100 days of age. No change in the quantity of histone 
H4 was found to occur in either myocyte or non-myocyte 
nuclear fractions from 21 to 10 0 days of age.
(These data suggest that RNA synthesis and histone 
acétylation during early cardiac hypertrophy are not 
coordinated in the naturally hypertrophying heart. The 
coordinated increase in total RNA polymerase activity and 
RNA synthesis occurring at 21 days of age would suggest 
that the DNA template availability does not limit 
transcription at this time point, and that possibly the 
increase in enzymatic activity and histone composition is 
sufficient to increase nuclear transcription without 
covalent modification of the core histones^
In the later stages of cardiac hypertophy (50 and 
100 days of age) the increased acétylation of nuclear his­
tone fractions and the decreased RNA polymerase activity 
would suggest that enhanced template availabiltiy regulates 
nuclear transcription,^ In this investigation 10 mM sodium 
butyrate was used to supress the enzymatic deacetylation of 
histones during the isolation of nuclei (Boffa et al.,
1978).  ^It is therefore unlikely that the level of internal 
acétylation of nucleosome core histones was effected by a
87
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deacetylation process during the prolonged isolation 
period.
(it would appear that RNA synthesis in the naturally 
hypertrophying heart is coordinated with DNA-template availa­
bility and RNA polymerase activity; however, the relative 
contribution of histone acétylation and enzyme activity 
varies with age.
(in summary, the reults of this investigation would 
indicate that;
1) RNA synthesis in the myocardium decreases with age, and
2) that during the early phase of cardiac hypertrophy,
DNA template availability and nuclear transcription 
are enhanced by alteration in core histone composition 
and RNA plymerase activity.
3) In the later phase of cardiac hypertrophy (100 days 
of age) RNA synthesis and DNA-template activity is 
enhanced by the covalent modificaion of nuclear 
histones.\
88
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Perfusion Buffer
Krebs-Henseleit Bicarbonate Buffer
A: Stock Solutions Working Solutions
KCl 11.50 g/1000 ml 40 ml 80 ml 120 ml
CaC12 (anhydrous) 12.20 g/1000 ml 36 ml 72 ml 72 ml
CaCl2 (dihydrous) 16.0 25 g/10 00 ml 36 ml 72 ml 72 ml
Ka2P04 21.40 g/1000 ml 10 ml 20 ml 30 ml
Mg S04.7H20 38.20 g/1000 ml 10 ml 20 ml 30 ml
Na2 EDTA 40.70 g/1000 ml 6 ml 12 ml 18 ml
B : Make fresh daily
Stock Volume Working Volumes
NaCl
DEXTROSE
NaHC03
1000 ml 
210 ml
Ix 2x 3x
9 g 18 g 27 g 
3.94 g 7.88 g 11.82 
2.715 g 5.43 g 8.15
g
g
Ra^îio-label 
3 (hJ acetate 
3 [h] uridine
D
(2 uCi/ml) 
(0.1 uCi/ml)
(1 ul/5ml) 
(1 ul/ml)
Procedure:
Dissolve NaCl and dextrose in 1,2, or 3 litres of 
double distilled water. Add KCl, CaC12, KH2P04, Mg S04. 
7H20 and NaEDTA in working volumes, and gas with 95% 02, 
and 5% C02 for 10 minutes. Add NaHC03 to 210, 420, or 
630 ml of double distilled H20 and continue to aerate. 
Remove volume for radiolabelling (30 ml/heart) and add 
radioactive label, continue to aerate. Remove sample from 
radioactive buffer (0.5 ml) and determine specific activity 
prior to perfusion of hearts (3 acetate, 800,000 CPM/ml)
( 3[l^  uridine, 80,000 cpm/ml) .
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Isolation of Ventricular Nuclei Isolation of Myocyte and 
Non Myocyte Nuclei and Extractions of Myocyte and Non 
Myocyte Nuclear Histones
A; Stock Solutions
1) 10 X  Stock
a) 10 0 mI-1 Tris HCl pH 8,0 
(12.11 g/1000 ml)
b) 10 mM Mg Cl2 (2.03 g/1000 ml)
c) 10 0 mM Na Butyrate
2) 1 X Stock
a) dilute 10 x stock double distilled water
3) Solution A
a) add 85.57 g of sucrose to 1 x stock, 
stock, dilute to 1000 ml
4) Solution B
a) 0.1% Triton x 10 0 in Solution A
5) Solution C
a) add 188.27 g of sucrose to Solution A, 
dilute to 250 ml in graduated flask
6) Sucrose Gradients
a) 2.0 M sucrose, 55% W/W,. in 1 x stock
b) 2.3 M sucrose, 61% W/W, in 1 x stock
c) 2.7 M sucrose, 69% W/W, in Ix stock
7) Solution D
a) 0.14 N NaCl, 2.045g/250 ml of 1 x stock
8) Solution E
a) 0.25 N HCl in double distilled water
9) PMSF
a) 0.1 M PMSF in 9 5% ethanol.
b) just prior to isolation add 1 ml/1000 
ml to stock solutions
B : Procedure: Isolation of Ventricular Nuclei
1) Thaw hearts in Solution A, on ice, trim 
hearts of atria and large vessels, split 
ventricles,- blot dry, weigh.
2) Mince tissue, homogenize in Solution A. 
centrifuge at 10,0 00 RPM for 10 min, 
discard supernatant.
3) Homogenize pellet in Soluttion A, filter 
through two layers of nylon mesh, scrape 
off unhomogenized tissue, re-homogenize, 
filter.
4) Rinse filter wiith Solution A, centrifuge, 
discard supernatant.
5) Homogenize pellet in Solution B, filter 
through metal mesh filter, in vacuum, on 
ice, centrifuge, discard supernatant.
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6) Allow pellet to drain by inversion for 
10 minutes.
7) Homogenize pellet in Solution C bring 
to calibrated volume, carefully layer 
onto 5 ml of ice cold Solution C, balance, 
centrifuge at 25K for 60 min in Ultra­
centrifuge .
Isolation of Myocyte and Non-Myocyte Nuclei
8) Discard supernatant, pool nuclei in 4.3 
ml 2.0 M sucrose. (See procedure note).
9) Carefully layer over 1.1 ml each of 2.3 M 
and 2.7 M sucrose.
Balance with 2.0 M sucrose, centrifuge 
at 25K for 120 minutes.
10) Remove 2.0 M sucrose, discard.
11) Carefully remove myocyte nuclei at 2.3 M,
2.7 M sucrose interface with modified 
Eppendorff.
12) Stir and scrape tube, remove 2.7M sucrose 
and non-myocyte nuclei, rinse with Solution 
D.
Extraction of Myocyte and Non-Myocyte Nuclear Histones;
13) Add 10 ml of Solution D to each nuclear 
fraction, centrifuge at 10,0 00 RPM for 
10 min,and discard the supernatant.
14) Add 2 ml of Solution D to each nuclear 
fraction, allow to stand 10 min, centri­
fuge, discard supernatant.
15) Extract nuclear histones twice with 1 ml 
each of Solution E, on ice, for 30 min, 
stirring every 10 min, centrifuge at 
12,000 RPM, combine supernatants,
16) Precipitate supernatants in 3 0 ml of 
acetone overnight in refrigerator.
17) Stir and scrape walls of precipitating 
tube, centrifuge at 3000 RPM for 20 min.
18) Remove all but 5 ml of acetone, resus­
pend precipitated histones, transfer to 
conical tubes, centrifuge at 30 00 RPM 
for 10 min, discard supernatant.
19) Cap conical tube with parafilm, puncture, 
place in dessicator for 60 minutes.
20) Solubilize histones with 300 ul of O.OIN HCl
with 15% sucrose, stir every 10 min, for
60 min, centrifuge at 30 00 RPM, extract 
supernatant and save for protein de­
termination and gel electrophoresis.
Save pellet for DNA determination.
n n
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C; Procedural Notes :
1) Do not use more than 3.0 g (wet weight) per sample.
2) Each isolation will yield 3 samples, using an SW25.1
rotor.
3) For isolation of myocyte and non-myocyte nuclei;
Age Number of Number of Starting wet weight
samples hearts/sample per sample
21 days 1 9 1. 8 g
50 days 3 2 3.0 g
100 days 3 2 3.0 g
4) It is important to make sucrose gradients prior to 
isolation, and remain on ice until time of use.
10 0
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX C
]nl
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Lowry Protein Determinations
A: Stock Solutions:
1) 2% Na2 HC03 in 0.1 N NaOH
2) 2% NaK Tartrate
3) 1 N Phenol-Folin Reagent
4) 1% CUS04
5) Histone Standard (1 mg calf thymus 
histone/10 ml double distilled H20)
B: Solution C:
Make fresh daily, add in this order:
1) 0.5 ml 1% CUS04
2) 0.5 ml 2% NaK Tartrate
3) 50 ml 2% Na2 CO3
C: Procedure:
1) Make sample standard of histone protein by using 
20,40,60,80 ul aliquots, and two blanks.
2) Remove 20 ul aliquots from samples.
3) Add 0.1 N NaOH to samples and standards to a final
volume of 0.4 ml.
4) Add 2 ml of Solution "C".
5) Vortex, and wait 10 minutes.
6) Add 0.2 ml of 1 N phenol-folin reagent.
7) Vortex, wait 30 min for development of color
reaction, not more than 45 minutes.
8) Read absorbance in spectrophotometer at 750 nm.
9) Determine protein concentration using Beer- 
Lambert equation.
10 2
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Determination of RNA Content
A; STock Solutions:
1) Orcinol Reagent
a) make fresh, just prior to assay.
b) dissolve 0.5 g FeCl 3 in 10 0 ml of 
concentrated HCl, add 1 g purified 
orcinol.
2) RNA Standard
a) dissolve 1 mg yeast RNA/ml 2% Na acetate,
B; Procedure:
1) Make sample standard of RNA by using 20,40, 60, and 
8 0 ul aliquots and two blanks.
2) Make sample unknown using 50 0 ul.
3) Dilute sample standards and unknowns with 1.5 ml of 
double distilled H20.
4) Add 1.5 ml of orcinol reagent, vortex, lightly cap 
test tues.
5) Place in boiling water for 20 minutes.
6) Read absorbance at 660 nm.
10 4
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Determination of DNA Content
A: Stock Solutions:
1) Diphenylamine
2) Reagent grade H2S04
3) Aqueous Acetaldehyde (16 mg/ml)
4) 5 mM NaOH
5) Glacial Acetic Acid
6) Calf Thymus DNA 
B ; Reaction Solutions :
1) DNA standard
a) 2 mg DNA/ml 5 mI4 NaOH
b) hydrolize equal volumes of DNA 
standard and 1 N PCA for 15 min at 
70 C, prepare fresh daily.
2) Diphenylamine Reagent
a) make fresh daily, prepare just prior 
to analysis
b) dissolve 1.5 mg of diphenylamine 
in 10 0 ml glacial acetic acid, add 
1.5 ml of H2S04.
c) add 0.10 ml/20 ml of aqueous acetal­
dehyde, and stir mixture.
C ; Procedure :
1) Make sample standard of DNA using 20,40,60, and 80 
ul aliquots, and two blanks.
2) dilute samples to 1 ml with 0.5 N PCA.
3) Add 2 ml of diphenylamine solution and vortex.
4) Incubate to 20 hours at 30 C.
5) Read absorbance at 600 nm.
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Determination of Nuclear DMA
Procedure:
1) Spin down nuclear pellets which were in 0.25 N HCl
at 10,000 RPM for 10 minutes.
2) Drain off supernatant.
3) Hydrolize pellet, twice, at 80 C with 0.5 ml each of
0.5 N PCA, for 30 min, stirring every 10 minutes.
4) Centrifuge at 3000 RPM for 10 min, keep supernatants.
5) Determine DNA content by Burton Diphenylamine reaction,
108
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Histone Polyacrylamide Electrophoresis
A: Solutions 1) Solution A
0.4% bisacrylamide + 60% acrylamide
a) make in an erlenmeyer flask pre­
calibrated to 50 ml with stirring bar,
b) add 0.2 g bisacrylamide and dissolve 
in 10 ml of double distilled water.
c) use a funnel to add 30 g of 
acrylamide.
d) wash walls of funnel and dilute to 
50 ml.
e) cap and store at room temperature.
2) Solution B
4 3.2% glacial acid + 4% TENED
a) add 21.6 ml of glacial acetic acid 
and 2.0 ml of TEMED, dilute to 50 
ml with double distilled water,
b) cap and store in refrigerator.
3) Solution C
10 M urea (120.12 g/200 ml)
4) Running Buffer
0.9 N acetic acid (108 ml/2000 ml)
5) Staining Solution
a) 0.1% amido black in 7% acetic acid 
with 20% ethanol.
6) Destaining Solution
a) 7% acetic acid + 20% ethanol
B. Procedure:
Solution
A
B
C
Ammonium Persulfate
Number of Disk Gels
5
3 ml
1.5 ml
7.5 ml 
0.015 g
10 
6 ml 
3 ml 
15 m 
0.030
15
9 ml 
4.5 ml 
122.5 ml 
0.0455 g
2) add solutions A,B, and C in order
3) cover, punch holes in cover, and 
deaerate overnight in desicator
4) add ammonium persulfate
5) cast gels
110
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Precipitation and Extraction of Myocardial Protein 
A: Procedure
1) Precipitate sample overnight in 10 ml of 
10% TCA at 0-4°C.
2) Centrifuge at 30 00 RPM, for 10 min, discard 
supernatant.
3) Wash precipitate with 2 ml of 5% TCA, centri­
fuge, discard supernatant.
4) Wash precipitate with 2 ml of 5% TCA, boil 
for 15 min, centrifuge, discard supernatant.
5) Wash precipitate twice with 2 ml each of 
5% TCA, centrifuge, discard supernatant.
6) Wash precipitate twice with chloroform: 
methanol: ether (1:1:1), centrifuge, discard 
supernatant.
7) Wash precipitate with ether, centrifuge, dis­
card supernatant.
8) Dissolve precipitate in 10 ml of IN NaOH 
(2 ml for 21 day hearts), at 40°C, over­
night.
112
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Determination of Nucleic Acid Content
Stock Solution :
1) 0.5 N PCA
2) 9 5% ETOH
3) Ether (anhydrous)
B; Procedure :
8
9
10
11
12
13
14
15
Sacrifice animal
Place heart in 0.14 N saline solution, 
on ice
Trim heart of large vessels and atria 
Split ventricles and blot dry on absorbent 
towelling, weigh tissue 
Mince tissue
Homogenize in Potter-Elvehjem tissue homo- 
genizer with 4 ml of double distilled H20 
Remove 3, 1 ml aliquots for protein de­
termination, RNA determination, DNA 
determination
Add 4 ml of 0.5 N PCA and allow to stand 
on ice overnight
Centifuge for 5 min at 30 00 RPM save super­
natant for cytoplasmic pool determinations 
Wash with 5 ml of 0.5 N PCA centrifuge, dis­
card supernatant.
Wash twice with 9 5% ETOH,centrifuge,discard 
supernatant.
Wash once with ether,centrifuge,discard sup­
ernatant, and allow precipitate to air dry. 
Extract nucleic acids twice with 3 ml each 
(1.5 ml for 21 day hearts) of 0.5 N PCA 
for 30 min at 80®C, stirring every 10 min. 
Pool extracts.
Determine RNA content by Orcinol reaction, 
DNA content by Burton diphenylamine re­
action
114
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Isolation of Nucleotides
A; Washed 1 M Alamine-Freon Solution;
1) Bring 72 ml of alamine to a final volume 
of 125 ml with chloroform or freon.
2) Wash twice in a separatory funnel with 
0.01 N NaOH.
3) Wash three times with 0.01 M NaCl, 
discard supernatants.
4) On the last wash filter lower phase 
into a brown bottle with dry filter 
paper.
B: Procedure
1) Weigh and mince tissue.
2) Homogenize in 1 N PCA (1-10 ml).
3) Centrifuge at 30 00 RPM for 10 min.
4) Keep supernatant on ice.
5) Resuspend pellet in 1/2 volume (0.5-5.0 
ml) of 0.5 N PCA.
6) Homogenize,centrifuge,pool supernatants.
7) Take sample (40 ul) dilute 1:50.
8) Read OD of 1 ml at 260-280 nm.
9) Combine supernatants with 10% more by 
volume with washed alamine-freon solution,
10) Vortex 3-4 min.
11) Check pH of upper fraction,should be 
neutral or slightly basic. If acidic add 
0.1-0.2 2 ml of alamine-freon solution.
12) Centrifuge at 30 00 RPM for 10 min.
Remove supernatant,store on ice.
13) Take sample,dilute,read OD,determine per­
cent recovery.
14) If recovery is less than 85% re-extract 
pellet with 1 ml of double distilled 
water,centrifuge,pool supernatants, 
determine percent recovery.
15) Measure volume extracted.
]] 6
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Determination of RNA Polymerase Activity 
A: Incubation Mixture (pH 7.5):
5mM PEP
20 ug PK
0.4 mM CTP
0. 4 mM ATP
0.4 mM GTP
0.0 24 mM 3 [ hJ UTP
50 mM TRIS HCl
2.2 mM MnCl
300 mM (NH4)2 S04
B: Make incubation mixture in the following order,
keep on ice.
1) Solution A:
a) add 0.217 g MnCl
1.982 g (NH4)2 S04 
0.30 3 g TRIS HCl
b) dilute to 45 ml with double dist­
illed water.
c) adjust pH to 7.5 with 1 N HCl or 
1 N NH4 OH.
d) bring to a final volume of 50 ml 
with double distilled water.
2) Solution B:
a) add 0.0293 g PEP 
0.0005 g PK 
0.0 053 g CTP 
0.0 063 g ATP 
0.0057 g GTP 
and dilute to 25 ml with solution A,
Procedure;
1) Suspend nuclear pellet in 0.5 ml of 
incubation mixture.
2) Remove 10 0 ul sample for blank.
3) Add 1 ul of UTP (2 uCi/ml; 4 3 Ci/ 
itiMole) to pellet and incubate for 15 min.
4) At time=14 min remove 10 0 ul aliquot,spot 
on 3 mm Whatman filter disk,allow to air 
dry (hold filter disc with forceps).
5) At time=15 min submerge filter disk in 
10% TCA with O.IM sodium pyrophosphate 
for 30 min,on ice.
6) Submerge filter disk in 1% TCA for 15 min 
on ice.
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7) Wash filter in ethano1-ether (3:l,v;v) for 
5 min.
8) Wash filter in ether for 5 min,on ice.
9) Allow to air dry.
10) Place in counting vial with LS cocktail 
and determine radioactivity.
11) Determine DNA content in remaining pellet.
Note; Zero time blanks are washed seperately to eliminate 
wash-out contamination from radio-labelled filters.
3 10
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HEART WEIGHT
(GRAMS)
DAYS OF AGE 21 50 10 0
0.312 0.767 1.65
0.285 0.863 1.31
0.295 0.676 1.63
0.265 0.703 1.32
0.262 0.790 1.54
0.285 0.742 1.65
0.262 0.639 1.38
1.48
1.29
1.17
MEAN 0.0 28 0.7 35 1.43
S.D. 0.018 0.071 0.18
S.E.M. 0.007 0.071 0.04
12.1
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BODY WEIGHT
(GRAMS)
DAYS OF AGE 21 50 10 0
64.5 225.7 632.6
62.0 237.4 618.6
62.9 213.8 593.7
53.6 208.8 502.2
61.9 226.9 454.7
62.2 218.8 534.4
56.5 203.3 497.6
511.4
494.0
467.9
MEAN 60.51 223.1 517.5
S.D. 3.93 9.01 64.14
S.E.M. 1.60 3.68 16.03
122
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RNA
(mg)
DAYS OF AGE 21 50 10 0
0.92 1.46 1.93
0.96 1.57 1.37
1.21 1.23 1.91
1.29 1.34 1.43
• 1.09 1.67 1.65
0.96 1.63 1.82
0.99 1.40 1.68
0.95 1.60
1.06 1.72
1.80
MEAN 1.05 1.47 1.70
S.D. 0.12 0.16 0.17
S.E.M. 0.05 0.06 0.04
12?
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RNA
(mg/gram)
DAYS OF AGE 21 50 10 0
3.48 1.90 1.17
3.13 1.82 1.03
3.87 1.83 1.17
4.53 1.90 1.09
3.72 2.11 1.07
3.79 2.08 1.10
3.59 2.19 1.22
3.33 1.08
4.03 1.34
1. 54
MEAN 3.84 1.9 8 1.20
S.D, 0.38 0.15 0.17
S.E.M. 0.15 0.06 0.04
12 4
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
DNA
(mg)
DAYS OF AGE 21 50 10 0
0.58 1.04 1.11
0.65 0.99 1.26
0.53 0.85 1.24
0.55 0.90 1.13
0,54 0.96 1.38
0.59 0.98 1.29
0.55 0.91 1.24
1.09
1.15
1.10
MEAN 0.57 0.95 1. 17
S.D. 0.04 0.07 0.09
S.E.M. 0.02 0.03 0.02
12 5
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DNA
(mg/gram)
DAYS OF AGE 21 50 10 0
1.85 1.36 0.68
2.28 1.16 0.70
1.81 1.26 0.76
2.07 1.28 0.85
2.06 1.22 0.89
2.08 1.26 0.78
2.11 1.42 0.90
0.74
0.39
0.94
MEAN 2.04 1.28 0.83
S.D. 0.16 0.09 0.08
S.E.M. 0.06 0.04 0.02
12 6
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RNA/DNA RATIO 
DAYS OF AGE 21 50 10 0
MEAN
1.58 1 1.48 : 1 1.73 ; 1
1.48 : 1 1.57 : 1 1.48 : 1
2.28 : 1 1.45 ; 1 1.54 ; 1
2.02 • 1 1.49 : 1 1.27 : 1
1.63 ; 1 1.73 : 1 1.19 : 1
1.80 ; 1 1.65 : 1 1.41 : 1
1.54 : 1 1.36 ; 1
1.46 : 1
1.85 1 1.55 1 1.45 ; 1
3 27
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PROTEIN
(mg)
DAYS OF AGE 21 50 10 0
8.21 54.21 63.59
9.49 66.80 85.86
10.26 49.82 95.24
8.91 54.21 80.00
9.49 64.76 68.57
9.67 58.61 81.17
8.79 43.08 84.98
72.67
84.40
69.45
MEAN 9.26 55.9 3 7 8.59
S.D. 0.67 8.28 9.76
S.E.M. 0.28 3.38 3.25
128
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PROTEIN
(mg/gram)
DAYS OF AGE 21 50 10 0
26.32 70.70 38.60
33.36 .77.46 47.53
34.81 73.74 58.36
33,67 77.14 51.94
36.29 82.01 49.13
33,88 79.00 49.13
33.53 67.43 61.46
48.93
65.58
59.49
MEAN 33.12 75.35 53.29
S.D. 3.17 5.04 7.97
S.E.M. 1.29 2.06 2.66
] 20
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DNA/PROTEIN RATIO
DAYS OF AGE 21 50 10 0
0.07 : 1 0.02 : 1 0.02 : 1
0.07 : 1 0.01 ; 1 0.01 ; 1
0.05 : 1 0.02 : 1 0.01 : 1
0 . 0 6 : 1  0.02 : 1 0.02 : 1 
0.05 : 1 0.02 : 1 0.02 : 1
0.06 : 1 0.02 : 1 0.02 : 1
0.06 : 1 0.01 : 1
0.06 : 1 0.01 : 1
0.01 : 1 
0.01 : 1
MEAN 0 . 0 6 : 1  0.02 : 1 0.02 ; 1
13H
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RNA/PROTEIN RATIO
d a y s  o f  A G E
MEAN
21 50 100
0.11 : 1 0.03 : 1 0.03 : 1
0.10 : 1 0.02 ; 1 0.0 2 : 1
0.12 1 0.02 : 1 0.02 : 1
0.14 ; 1 0.02 : 1 0.02 : 1
0.11 : 1 0.03 ; 1 0.02 : 1
0.10 ; 1 0.03 : 1 0.02 : 1
0.11 : 1 0.03 : 1 0.0 2 : 1
0.03 : 1
0.11 1 0.03 , 1 0.02 : 1
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RNA + DNA / PROTEIN 
RATIO
DAYS OF AGE 21 50 100
0.18 : 1 0.05 : 1 0.05 : 1
0.17 : 1 0.04 : 1 0.04 : 1
0.17 : 1 0.04 : 1 0.03 : 1
0.21 : 1 0.04 ; 1 0.04 : 1
0.17 ; 1 0.04 ; 1 0.04 : 1
0.16 ; 1 0.04 ; 1 0.03 : 1
0.17 ; 1 0.05 : 1 0.04 : 1
0.03 ; 1 
0.04 : 1
MEAN 0.18 : 1 0.04 : 1 0.04 : 1
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DAYS OF AGE
H URIDINE INCORPORATION (DPM /mg RNA)
21
331822
588486
790068
569419
280884
704111
289138
467451
377362
377205
578300
351024
311392
341641
50
66757
34954
110757
115000
80678
137119
10 0 
39508 
94719 
81484 
26824 
1379 64 
65278 
121311 
88967 
55001 
79997 
55943 
53727 
47359 
37943 
98867
MEAN
S.D.
S.E.M.
480394 
17149 5 
44278
90878
12769
1519
72320
31902
8526
13 3
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CYTOPLASMIC URIDINE NUCLEOTIDE POOL 
(DPM / uM URIDINE NUCLEOTIDE)
DAYS OF AGE 21
209866
111987
213838
50 
249 257 
253398 
182988
10 0 
111158 
96563 
169455
MEAN
S.E.M.
178564
33309
228548
22812
125725
22268
13/)
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RNA POLYMERASE ACTIVITY 
(p moles / mg DNA)
DAYS OF AGE 
TOTAL ACTIVITY
21
2498
2200
1985
50 
10 89 
1417
100 
119 4 
1422 
1236
MEAN
S.D.
S.E.M.
%
2228
258
182
1118
41
41
1284
121
86
MYOCYTE ACTIVITY 824 
59 7 
427
503
528
769
1014
775
MEAN 616
59
41
515
18
18
853
140
99
n o n -m y o c y t e a c t i v i t y 1675 
1602 
15 59
586
567
425
408
461
MEAN
S.D.
S.E.M.
1612
59
41
577
14
14
431
27
19
13 5
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TOTAL HEART HISTONES
(% DISTRIBUTION)
HISTONE FRACTIONS
AGE
21 DAYS
HI 
22.96 
25.47 
21. 81 
22.44 
20.16
HI
1.82
3.07
1.82
2.34
2.00
H3
18.90
18.30
18.36
23.42
24.52
H2A+2B
44.43
41
38
36
40
00
46
11
52
H4 
11.87 
12.16 
19 . 63 
15.70 
12.79
MEAN
S.D.
S.E.M.
22.57
1.93
0.97
2.19
0.54
0.27
20.70 
3.02 
1. 51
40.10
3.10
1.55
14.43 
3.28 
1. 64
50 DAY 25.60 
25.16 
22. 88 
31.92 
21.15 
22.19
3.27
2.97
1.91
3.69
2.16
2.67
13.33 
15.61 
17.82 
11.78 
19 .53 
19.39
51.42
45.68
46.86
47.23
44.26
43.37
6.39 
10.58 
10 .52 
5.37 
112.90 
12.39
MEAN
S.D.
S.E.M.
24.82 
3.8 8 
1.50
2.78
0.67
0.30
16.24
3.23
1.44
46.47
2.84
1.27
9.69
3.12
1.40
100 DAY 22.27
20.88
20.16
18.29
2.43
2.49
2.71
3.68
15.45
15.03
18.33
18.76
44.59
48.94
44.47
43.90
15.26 
12. 65 
14.33 
15.37
MEAN
S.D.
S.E.M.
20.40 
1. 66 
0.96
2.83
0.58
0.34
16.89
1.92
1.11
45.48
2.33
1.34
14.40
1.26
0.73
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MYOCYTE NUCLEAR HISTONE
(% DISTRIBUTION)
HISTONE FRACTIONS
AGE
21 DAYS
Hi
6.14
2.14 
5.03
HI
16.26
13.30
13.16
H3 
44.27 
49 .29 
49.60
H2A+2B
20.79
21.62
20.35
H4 
12.10 
13. 65 
11.78
MEAN
S.D.
S.E.M.
4.44
2.07
1.46
14.24
1.75
1.24
47.89
2.76
1.95
20.92
0.64
0.46
12.51
1.00
0.71
50 DAYS 5.21
5.93
5.64
5.71
29.57 
32.08 
29 .47 
28.88
7.89
9.23
5.65
5.82
52.07 
48. 12 
51.47 
52.81
5.26
4.64
7.78
6.78
MEAN
S.D.
S.E.M.
5.62
0.30
0.17
30.00
1.42
0.82
6.85
1.63
0.94
51.11
2.07
1.20
6.11
1.43
0.82
100 DAYS 7.24
6.32
6.89
26.65
23.40
25.11
4.16
6.68
5.41
51.96
52.95
52.92
9 .99 
10.65 
9.67
MEAN
S.D.
S.E.M.
6.82
0.46
0.33
25.05
1.63
1.15
5.42
1.26
0.89
52.61
0.56
0.40
10.10
0.50
0.35
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NON-MYOCYTE NUCLEAR HISTONE
(% DITRIBUTION)
AGE
21 DAYS
HI 
17.21 
18.33 
20 .13
HISTONE FRACTIONS
HI H3 
23. 65 
24.48 
28.13
H2A+2B
45.47
43.63
45.83
H4 
13. 68 
13. 57 
13.01
MEAN
S.D.
S.E.M.
19 .21 
2.58 
1.82
25.42 
2. 38 
1.68
44.98
1.18
0.83
13.42
0.36
0.25
50 DAYS 33.15
32.92
31.88
4.29
5.01
4.92
23.88 
27. 83 
25.86
34.61
30.00
32.45
4.06
4.24
4.89
MEAN
S.D.
S.E.M.
32.65
0.68
0.48
4.74
0.39
0.27
25.86
1.97
0.71
32. 35 
2.31 
1.63
4.40
0.44
0.31
100 DAYS 33.50
26.04
28.68
4.58
5.17
4.49
26.21 
32.67 
30 .17
29.83
22.81
25.66
5.87
13.81
11.00
MEAN
S.D.
S.E.M.
29 .41 
3.78 
2.67
4.75
0.37
0.26
29.68
3.26
2.30
26.10
3.53
2.50
10 .06 
3.81 
2.69
138
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
NON-MYOCYTE NUCLEAR HISTONE ACETYLATION
(DPM / % HISTONE)
AGE
2IDAYS
HISTONE FRACTIONS 
HI HI H3
1173 1511
1736 2392
690 1678
H2A+2B
718
729
708
H4
1015
1307
1307
MEAN
S.D.
S.E.M.
1200
524
370
1678
691
489
708
29
20
1307
92
65
50 DAYS 19 08 
1713 
1704
14380
14983
12134
2390
2310
2404
1670
2097
1698
14320
13630
17446
MEAN
S.D.
S.E.M.
1775
115
81
13832
1501
1062
2368
51
36
1822
238
169
15132
2033
1438
10 0 DAYS 1634
2140
1862
13144
11894
12202
19 27 
1854 
1893
1833 
28 39 
2171
9154
3801
4870
MEAN
S.D.
S.E.M.
1878
253
179
12413
651
461
1891
36
26
2408
518
366
5972 
2799 
19 79
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MYOCYTE NUCLEAR HISTONE ACETYLATION
(DPM / % HISTONE)
AGE
21 DAYS
HI
2736
9720
3285
HISTONE
HI
2944
2604
1031
FRACTIONS
H3
691
401
586
H22A+2B
1198
1156
1025
H4
876
1208
2125
MEAN
S.D.
S.E.M.
5247 
388 3 
2746
219 3 
1021 
722
559
147
104
1127
91
64
1403 
64 7 
457
50 DAYS 1119 4 
9256 
9638 
9632
2163 
1857 
19 94 
19 9 2
7947 
5804 
11057 
10 518
110 2 
1225 
1137 
1147
10801
12893
7189
8599
MEAN
S.D.
S.E.M.
9930
861
497
20 01 
12 5 
72
8822
2420
1397
1153
52
30
9871
2504
1446
10 0 DAYS 10 07 3 
9035 
7562
2728 
2578 
279 2
13453
8215
13646
10 23 
10 27 
962
5359
5130
5802
MEAN 
S.D. ' 
S.E.M.
8890
1261
892
2699
109
77
11771
3081
2179
1003
36
25
5430
342
242
.1 4 0
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APPENDIX N
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,c.- Tp:. r , zc/.'-," ci r;.-i- rccTCM-',
zv'JPCE Of: DEGREES OF SUM OF MEr.N
-cr-pTT^,, r:.r--,r,v SQURRES SO'jRRE _ F-PR^ IO
EETWEEN 2 R7S295.291 489147.645 283.534473
i-aTHIIJ 21 36228.7529 1725.17871
TOTAL 23 1014524.04
4 4->!'4:'4:4:4:M:4:4'4:4:4'4'4 4'4 4: 4 4:4 4
HER:- HEIGHT
ÜHE-HRV TNOVR'- TABLE iRAUDOM BLOCK DESIGN
"''.!:3E OF TEGREES OF SUM OF MEAN
V-='IRTION FREEDOM ' SOURP.ES SOURRE F-RATIO
BET.'EEU 2 6.35595224 3.17798112 158.934694
lilTHIN 21 395049721 0188118915
:"A L  23 5. 75101196
SOURCE OF DEGREES OF SUM 0- MEAN
VR-IATION FREEDOM SOUFRES SQUARE F-RATIO
BETWEEN 2 1 62948652 .814743262 140 310059
WITHIN 21 .121941425 5.80573452E-03
TOTAL 23 1.75142795
DNA CONCENTRATION (MG.GRAM-1)
ONE-WA'-' ''A'OVA-' TABLE (RANDOM BLOCK DESIGN)
SOURCE OF DEGREES OF SUM OF MEAN
'•.ARIATION FREEDOM SQUARES SQUARE F-RATIO
BETWEEN 2 6.17720963 3.88:850482 235 213211
WJTrilN 21 275752798 .0131310856
TOTAL 23 6 45296243
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C'.6-..hT TABLE BLOCK DESIGN:' •
SO .'ALE jF degrees OF SUM OF MEAN
ViRIhTION FF EEROM SOUFT'ES SQUARE F-RATIO
BETWEEN 2 2. Oct iSE57 i. 17809x28 57.40246'?9
WITHIN 23 471793413 .6205.127571
= '.'A C'jNOE'i'RATI'jN (MG GRAM-1)
ONÈ-.(AY TABLE (RAsROM RL'CK "ESIGtO
* * i-sT;-. y.;i-v r ; . '4;^ y -1,
SOURCE OF DEGREES OF SUM OF MEAN
.'A: "ATIOfj FFEEOOM S '^U-ES SQUARE F-RR'IO
BExiEEN 2 31.3569525 15.5"> 153 212. 02513
..'■-IN 21 _ T;07t1T 6739h572T
-C-AI. 25 33 057A0L4
■■"AL FRj-EIN (MG)
ONE-WAY 'ANOVft' TAB'lE ':PANW BLOCK DESIGN)
SO'. : OE 'IF DEGREES A-
(FAIR:18: FREEDOM
BETWEEN 2
tl»—
:i:
total
30”' OF 
SQUARES
19955. /IS-: 5 
12“1 693R:
21237. 6981
MEAN
SQUARE F-Rfi"IO
9982. 76224 164. ^ 4^ 4
50. 5558412
■ f"-."-. Y':-'.; j:+ YH':*:
RF-'OTEIli CONCENTRATION (MG. GRAM-1 ) '
INE-./AY 8N:'"A ' TRRLE (RANDOM BL;;3( DESIGN)
SC".:RDE OF DEGREES OF SUM OF MEAN
■^■ARIATION FREEDOM SQUARES SQUARE F-RATIO
BETWEEN 2 624“ 4:.M67 3123 72764 83. 723D851
N"WN 'M 783 567262 37.3698669
14 3
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' ■ ? i.jr • N:-::FE::.T:ON DFM
'ANy4 TAB:_E (AA-.'OM El'OCF DESIGN'.
S’OLACE OF DEGREES OF SUM OF MEAN
'--"AT I ON FPEEI'OM SOiUAFES S*'U":E - F-RATIO
BETWEEN 2 1. 34935415E+12 S.745?707SE+ii 61 2Î8F37?
;.r-.:N 25 3 ::5i012A.SF"li 1 101717S7E+10
TOTAL ■? 1. 72<95544E+12
>y-:4:y;< -‘rXYs::   - • -: - ■■'i Mi
TOTAL TISSUE [N'A.-'FROTEIH RATIO
ONE-WAY -ANOVh' TABLE (RANDOM BLOCK CtSIGN)
SOURCE OF [AGREES OF SUM OF MEA'I
v: r:ATION FFEEC'M SOUFRES SQUARE F-RATIO
BETWEEN 2 . 0101575464 5. 07877:22E-03 350. 407766
20 2. 898778915-04 1,4^9:89466-05
TOTAL 22 .010:47424:
TOTAL TISSiJE{p;A.(RRDTEIN RATIO
ONE-WAY 'ANOVA-' TABLE (RANDOM BLOCK DESIGN)
SIURCE OF DEG-:EES C" SUM OF MEAN
VARTATION FREEDOM SQUARES SQUARE F-RATIO
EEx.'EEN 2 .0405424602 020:212:01 285 "89141
WITHIN 21 1. 4969:8125-'": 7, 128276"4E-05
TOTAL 23 .042139:383
TOTAL TISSUE PN“ -DNA RATIO
ONE-WAY 'ANOVA' TABLE (RANDOM BLOCK DESIGN)
SCUF'CE OF DEGREES OF SUM OF MEAN
•ii RPEEDOM S"'DARES SQUARE F-RRTIO
.••. 4"i"! '4' ; •4.-4”i‘4::i;;4'4--i:'4 *4 :4Mt;'iy4::4%iW:U UT-j-Vyj-1 1-%-4y,'iy4'4T?4)4'*'*"4 :*'> • • '* * * '*-;4*x.J:'*::4:^>tS.'4:'4*'4’ ir-4;>S''*r:4:)4;
BETWEEN 2 .751829773 375914887 7.64382984
WITHIN 21 1. 03275619 .0491788664
TIFSL 23 1 78458597
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TOTAL TlSrUE R'F^ DNA/pPt'-'EIN PATIO
O'.E-l'AV 'AN:.-.'A' TABLE (F.ANOOM ElOOK DESIGN)
SOjROF 0- DEGREES OF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE F-RATIO
0ETI.-EEN 2 .092-1624464 .0460812222 590,9122.48
WITHIN 21 1 62764675E-02 7.79821787E-05
TOTAL 22 . 0928000932
C^ 'TO^ LAS^ 'IC URIDINE N’JCLEv’ -DE =0‘1 'DPM UM-1 URIDINE NUCLEOTIDES)
ONE-!.':",' 'AND":' T^ 'BLE (RANDOM BLOCT' DESIGN)
SOURCE OF DEGREES OF SUM OF MEAN •
"A'I:TION TrrzfOM çOijAPES SQUARE' F-PP“ !0
E'E^HEEN 2 1 58627221E+10 ?. 92136102E+09 3. 73125201
U'"H:N 6 1 275359P7E+10 2 125599796^ 09
TOTAL 8 2. S616220SE+10
3H ACETYLATION 21 DA'-' MHODYTE HI . ■' • • •■ ' '  ’
ONE-WAY -'RNOVA'- TABLE (RANDOM BLOCK DESIGN)
BETWEEN 4 41158749.7 10289687.4 2.1047368
WITHIN 10 32141899.3 3214189.93
TOTAL 14 74300648 9
3H ACETYLATION 21 DR^' N'ON-MYOCYTE HI HIO H3 H2A+2B H4 
ONE-WAY 'RNOVA-' "ABLE (RANDOM BLOC": DESIGN)
S'URCE OfT DEGREES OF SUM OF MEAN
VR='I-TI0N FREEDOM SQUARES SQUARE F-PATIO
BETWEEN 4 5:98990 "5 1422245 24 13 0796624
:.ruiN 10 1097454 4-r 108745 466
"0"AL 14 , 6776435. 6
•. ■ 4 .  4’-4 >  •* .  •«, * - * ; • • * • . ' ’< • *  : 1 ■• i' » ■* -i-'i'-i- I • : • ■ • • ' .  -i 1 ’ -g - i  -j •*• 4'-* « . •* *  - : -  •• •  •  .
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-u c:E-\:ATio!; 53 c.-v kv.t.v"e -:i -:5 H3 h:-:=
•û‘;*’»CK -^.z'r r-j rrrrr^^^s
:-4 i*'* 4  4:)^ g-g* i ’f  4-i .•*.•* **v-g*g*gs*:4
sg'.F:E Ù- DEgc'EES CF sum g- mean
VARIATION FREEDQ" SQUARES SQUARE . F-RR-IO
BETWEEN 4 309155Û37 77288759.2 29. 8527871
WITHIN 15 288:49^6 5 2588996. 42
4-r4:4”*;gvAWyi*4;4'4-*-4->f:a*4*4-4-4:4::f4r4:'f •4N::4-4::4;4-;f4*4*4r.4:4::4:)^
^OTPL 19 247989982
2- -CETVLATIOW 50 DAY NCN-irCCA'TE HI HIO H3 H2^ +2B H4
ONE-WAY 'ANCfVA'- TABLE (RANDOM BLOCK DESIGN)
SOURCE OF DECREES Cf SL"' CF ME-N
VARIATION FREEDO" SOUR: ES SQUARE F-^ ^F-IO
•^:'A” 4 r 4 * 4 y i ' »‘ A '4 ” A’4 **4;4 ‘4 y 4 '’l ‘ *4 4» ly j ;  4 *  j " i ; 4 "  f"« ;L *» 4  »* • i- j4 'W ^ *4 '4 ; : i; : i* 4 ;4 » 4 » > ;4 '4 -4 ;> '4 T 4 ’4 ; 4 ; 4 ” i ' \ ' 4 * ' i ' 4 ' * i 'C '> l * g '4 * v g 'g ’ ' j ”A- * '4 ,4 '  i ' 4 '  4  4y« ••
EETLEEl; 4 5E512Û811 141282703 109 320013
Ÿ4":'V 4'V'' •4"i'-J:4'4;^;^;'A-i:4- *-a 4-, 4;4y.i. g:> N;:4‘.4‘ >*4::4::*vf :-{:-A'>'4;'.4;4:4'4yi:4y^yi:4:4;4;'*'4;4"l'4.4:jJ'4:4"iyJ:4 "iyi-g 4' .-;i-'i->' j 4 4 4yi'
3H C'CE-YLATION 100 DAY MYOCYTE HI HIO H3 H2A/-2B H4 
ONE-WAY 'ANOVA' TABLE (RANDOM BLOCK DESIGN)
SOURCE OF DEGREES CF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE F-RA'^ IO
BETWEEN 4 232492760 58373189. 9 26 0197425
WITHIN 10 22424192 2243419. 2
TOTAL 14 255926952
3H ACETYLATION 100 DAY NON-MYOCYTE HI HIG H3 H2A+2B H4
ONE-WAY 'ANOVR' TABLE (RANDOM BLOCK DESIGN)
SOURCE OF DEGREES OF SUM CF MEAN
VARIATION FREEDOM SQUARES SQUARE F-RATIO
BETWEEN 4 247719513 61929878.3 35 2805987
WITHIN 10 17553522 5 1755352.25
-CTA:,. 14 265273036
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:H P'ET'-'L"":'. HI 21 5? 120 [-AYS
ONE-WAY "ANOVR-' TABLE (RANDOM BLOCK DESIGN)
SOURCE OF DEGREES OF SUM CF MEAN
'•'AR-IATICiN FREEDOM SQUARES SQUARE F-RATIO
%:4 4-»:4 .»"< 4 4'4:4:4-*.4 ;t:4-4'4:4'.»':»-» 4 '»:4:4'4T4:4'*'»-' i'tM'" 4-*r4"4:H:'f’+'‘:+>l''-'»!4:.*:4:i;i:4:4:4:4:.4:4;.4:4:.4;4:4;4:4;:i:.4;4:4:4;:4’4:+4"!:4:4-4:
BETWEEN 2 205623683 102S11S41 19.5681762
WITHIN 7 36778220. 3 5254032. 89
4 4:4 :,:4:4:4;4:4 4:4:4:4.4:4:4:4:4:4.4:4::4:.4:4.4:4 4 4:4:4:4 4:4:i'4:4:.4:4:4:4"»"4:4-i:i:i:i:t-/:4:4:4:4:*W:**i:*i:i:4 4 4.4:4:4:4:4.4:4:< :4.:.:4:4:4 44:
TCTAL 9 242401913
.<:4:4:-4:4:i:'i"(:i-i:i:X4:i-4:i:t:i-1:'|:'‘"*:'*-:4:i:i:i:4:t:4:4:ti:i:4:i:4:4:4:4-4:4:4:4:4:4:4'»'.».:4-4r«:4:4'4-4-4-'-:*:4'4:4t4:4:4:i:i:i:4:i:i:t:i:4:-»:4:4:4:
MvqCY-'E -:u ACET'-'LA^ IvN H2A-2B 21 50 100 DAYS 
ONE-WAY '■RNOVA'- TABLE (RANDOM BLOCK DESIGN)
4:i:t:4."<:4:.4:»'4:4:4:4-4:4:4:>"*'“ - ':4::':4:4:4:4r»:4:4:4:4.4:4:4:i:i 4:4:4:4"4 X4:4:4:i:i:i::4.4:4:i:4:4:4r»::4:4:'»:4:4:4:4r*:4.-4:4:i:*4:4:4:*4:4:4:4:4:4:.4:
SOl 'RCE CF DEGREES OR SIM OF MEAN
(AVIATION FREEDOM SQUARES .SQUARE., F-RATIO
BETWEEN 2 40858.1836 20:29.0918 5.293:'848
.«■I ”i 4‘ 4»' •.’■*' V 4 '-"**>•* *'^ '-4 "*  ^"i g» wg»g: i g g g g*g*^-:X'
. ; ; .J I ; i 4 4"» .:. ...,:.;.4..; 4 .i-.» .1 .|..i.4:44::^ ::j.ç 44..j:4 4'4: »::»:4:4:4::»:4:4:4:4:4::4:4T4:4:4..4 4:4:4:4:4 4:.i.:4:.»:4T4:4:44 4:4'4:4:4:4:4:
NVOCVTE 3H fiCETYLA"ION H4 21 50 100 DAYS 
ONE-WAY ''ANOVA'' TABLE 'RANDOM BLOCK DESIGN)
SOU=:CE OF DEGREES OF SUM CF MEAN
's - : a" : cn freedom squares square f- rrtio
BETWEEN 2 124275456 62137728.1 21.8829509
WITHIN 7 195:76848. 4 2839549.77
474:4:4:4:444.-4:4:4:'/:*^:':^:» ! -/-»:f:4:4'i:4:4:.»:»:4r»-4:4:4:*4:.»:»:4:4:4-4:4:4:4;4.?t:4.4::i:-»-i:i:':4=t:i:*:4:ki:i:i:.i:i:i:i:|:i:4:i:4:i:i:i-*i:$
TOTAL 9 144152305
4:-:'4:4.:4:/:4:4'4:1:/-:+:i"4:>t'.:r:‘:/:t:/:':-:* ■/:i:‘'X4:4:*.'f:t:4:.4:4:'*:*'4:4:*:t:‘:*:i::4::4:i::14:**:*:+*:*4:**4*:'»:4:i:*:t.'i:-i:****i:i:i;i:*-+:i4:*
NOn- ‘'-OC'tTE 3H ACETYLATION HI 21 50 100 DAYS
QNE-NRY '•RN'OVA' TABLE (RANDOM BLOCK DESIGN)
SCU"E OF DEGREES CF SU'-' 0  ^ MEAN
VARIATION FREEDOM SQUARES SQUARE F-RRTIO
B'ETl.'EEN 2 8C2796 227 401398.113 3 42522337
WrniN 6 703173 32 117188 887
g-J" ; * >: «g--••g” •<•'*• a "#y*-g »- g 'i-g» f g g.g'g«g- i»g g g«. g ; g g gg- g« vgyi- ••*'g:!|t;i*g*g g”*-v-g; g-g-g- g- g- g; g- g- -. . g g g >*'g-g:«»-i- «-g  ^g%^;g;gyf;4^ ;^
---;: C: .(ir.-.ri:,- r:;
' . * g-: g-g g J Uyj'C;g »- * g- g g-*; i g- d g <- J g gyi?g'g'gyj««^«g'g'g g g/^ -g^ g^ g g-g g "^;g;g; i;g g-i g "* g g-g g g-g -j g g.«^g g..*-
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MN-M-OIr'TE 3H' A'ET'tL-Tî QN -le  2l 50 100 '- v j  
ONE- ;AV '■AMÇVA-' TABLE FAN'-'OM BLOCK DEE I ON)
4 I Ÿ»::' 4 4 "*'> •”4'4t4:4'4*4:5»:4'4:.4:4:4:4:4:.+W'4‘4'4'4-j{:.4:
SOURCE ilT DEGREES CF SUM CF MEAN
VARIATION FREEDOM SQUARES SQUARE ' F-Rp-IO
g-g-g-M::*;. # g i:g g:g*g .-g- *:4;V::^ g g-g- i,'* i % g f :*:gr4 urVytv .* 4 g ; «"»T4 :4:4 T4 '4 ;4W'g:4:**4r4'4 :X:g 4 "*'4r4f>k4'4:4 rg"g'g' : 4 4 : 4 4:4 :4 :
BEx.'EEN 2 D47<-S50 i?3?lï?25 194. 5:6695
LTTuin 6 5256551 25 992758. 542
TOTAL S 252794402
n::N-'*.'C:C'-'TE 2H ACETYLATION H3 21 50 100 DAYS 
O'.E-L-Y 'ANOY'A' TABLE (RANDOM BLOCK DESIGN)
sdfce C'T deg' ees i:F sum of mean
'--::-TION FREEDOM SOU*='ES SQUARE F-RRTIO
BE-L'EEN 2 50D6P6. 991 251822.445 2.250^22^7
IN 6 /16.4901. 212 77466 9954
•«• 4 a* *;vy4*g i j';4 g '« g  g ay* 4 *. 4;g :4 **- • •i-g-y-.! . ."4y*» i;"^':y'g:g:y:g gy4'g:gyf'g:g'g g-N g-'* g-g g;g-g«g.g'g'g.g.g.g»g«g g g g.
NON-WOCVTE 2H ACETYLATION HQA^DB 21 50 180 DAYS 
OfCE-N^V -ANOVA' TABLE (RANDOM BLOCK DESIGN)
M:* *4.i::4y***:»:***y:i:*i4:i:*******i i'*****r»'.*:;:******:4: »:**:4:*y *:********:»:******:******:*:4:** «
SOURCE OF ['E j-'EES OF SUM OF l'ÎERN
VARIATION FC'EEDOM SQUARES SQUR^E F-RATIO
•i.g.g *y4*gyitgyjL*^|tv-gyi;f:i:tf;:4:4:g:'. g> g.g j ('g;g:gy!y4:4y:;gy.,;4yirg. ;.g;:4yj.;4'*4:4;g"4:-4:t:4':4:4y4:;*:i:+:4:$);:f:)4:i:)4:>^:)*:*tVT:^"g:4:4:*yM:g:'4:j:
BETWEEN 2 2929599, 56 1964794 78 IS. 4215993
WI'YIN 6 63959S 664 186599 777
TOTAL 8 4569183.22
*%*****:»'**.»S-**r***i:i'.**** :*.*.****i:*r*.***.»:* y.***********:f ****************:(:*********:*.*:W *
NON-MYOCYTE 3H ACETYLATION H4 21 58 180 DAYS
ONE-WAY 'ANOVA' TABLE (RANDOM BLOCK DESIGN)
SOLF'CE OF DEGREES OF SUM OF MEAN
VA.:'IAT'ON FREEDOM SQUARES SQUARE F-RATIO
»:* *:y:***********.»:**: (:***:*:**:***nk*:**:**-/:* *i:*:ir.**:***:*****:*:*i:*:*:*:***iM:**:t:*:*.****:tn**.»:*:1:****
BETWEEN 2 299538769 149765395 36. 9265492
WITHIN 6 24480665.5 4866777 53
TQ-AL 8 223931435
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M-'OC-TE VI L3N-MYÛ:--: 3H hCETtLATIO-; H QhV HI 
:':E-I:AY 'PNC 'A- TABLE 'Pft'.DOM BLOCK [ESIGN)
SCL'T'CE OF DEG-EEb OF SUM OF ' MEAN
VARIATION FREEDOM SGUPPES SQUARE F-RAIIO
BETWEEN 1 24571350.7 24571360.7 3.20039411
WyHIN 4 3071041S 6 7677604. 66
TOTAL 5 55201779.4
•V.;:VTE :'S ';0'.-'^VG:vtE 3H acétylation 21 DAY H3
ONE-WAY ''ANOVA'' TABLE (RANDOM BLOCK DESIGN)
S'^ âCE OF DEGREES OF SUM OF MEAN
L'-RIATION -REEDOM SC'UARES SQUARE F-RATIO
BETWEEN 1 2475B37. 5 24760:" 5 19 £105257
LHMlN 4 500105.132 125026.333
Tir^L 5 29"5942. £4
Mv:c-TE \'S NON-M'-'OCVTE 3H ACET’-’LATION 21 DAY H2A+2B 
ONE-WAY "ANOVA'' "^ AELE (RANDOM BLOCK DESIGN)
4"»' » 4 **4-y y *:l: 4:*:4:4:4: 4x4:4"4:4:4:4: 4 y *4:*:4:*:4:**:4:y.:4 **:4:*4:*4:**4 **"4 y:*y:***:|:**-4:**4:4:**:4:4: 4::4:*x4y:*4T**4:***
SOURCE OF DEGREES OF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE F-PATIO
•«•g « •*•••■ *' •»'<••» •»••*■*•' • ' g"#' *"*'g g g «' g--* g . - - -, ••*--. * ■. ••<••< »- j - .g g- g- gg-g—^»g- ■*••*• g* y g «g». g* g * * -A-a- •* *• g-g g*u**. . g
BE'VEEN 1 253341.502 2533^1.502 59. B03P723
WITHIN P 17913.3301 4472 33252
TOTAL 5 2S1254,832
MY'OCVTE VS NON-MYOCYTE 3H ACETYLATION 21 DRV H4 
ONE-WAY "ANOVA" TAElE (RANDOM BLOCK DESIGN)
y..»x4T*'4:M:*:4:4:*.4.*:4.*:4::4:*'4:*i 4:*i=!"4"4:i:i:*y:y:*:44:*i"4"'*t:i:i:i::4:*:4:* 4:*:4::!."4:*#::4.i:i:*:i::4.*:4:i.*i:*.i4:i:****i:y:*i::4..'t:
SOURCE OF DEGREES OF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE F-RATIO
gy4.;gy|.gy4:gy*.g.gy4;g;;4yg.g.gy*:g^.^;,^.|:^-.4;^:)4.jiy4.^.gy^.g
BETWEEN 1 3952?. 1641 39528.1641 .172282801
WITHIN 4 917750.672 229437.668
•*>•> gyi g v;g:yg:)&'gT:*'Ÿy:g;'^  gri'g%^:g '. g:gyj g:g\j:g:V' ;;g:< g-g-g-
TOTAL 5 957278 835
: -4 - i 4.g-g"••g-g-gyi; «yi-g-g.-*: g-g- *y^y»- i >■ i-g; g g?Vy4:;g'g:gy{yiyi' g^g ^fy^' i-g-*^ * g.g-gygygyiyjfgyi'g'g'gyi g a g^ gyi-g-g^ gwygg-g-.* g g.g g g..^
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•'•■"'TE vi7âN-KV0:v-E : h ACETYLATION 50 [ÿv HI ■ ”  ............
C-â-WRV ANCivA- TASlE (RANDOM BLOCK DESIGN)
SOURCE OF DEGREES OF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE " F-RATIO
EETIIEEH i  64944042. 9 64944042.9 5.91210736
WITHIN 5 54924614 10984922, 3
^C"AL 6 119S68657
***:»:*>("» **y *:4ri:y: 4':4:**i:'' *y "4:*: 4:i:**'4"4:i:i:y:i:i. 4.**:4'y:***y:i:y *******y:*i:*:i:y:***'4:******i:*'4:**i:i:***.-*
ITYOCVTE T'S NON-MYOCYTE 3H RCETMATION 58 DAY H18 
ONE-WAY "ANOVA' TABLE (RANDOM BLOCK DESIGN)
*-.»:y:*y **:**y:y:*:y y:M:4::4:i:***y-4:i'i:i-4:**:*i:*i:i:.i.-4:**:4:**i'**:i::4'i:**y"4'*i:***i:*:i:*:4:i4"4:i:***i:y:i"4:*:****'4:i:*
SOURCE OF DEGREES OF SUM OF MEAN
-RIA"ION FREEDOM SQUARES SQUARE F-RhTJO
BE-L'EEN 1 239946202 239946202 ' 263. :6:554
V - - - I N  5 4555417.75 911083 55
TOTAL 6 244501619
MYOCYTE VS NON-MYOCYTE 3H ACETYLATION 58 DAY H3 
ONE-WAY 'ANOVA' TABLE (RAND'OM ElOCK DESIGN)
.4.**:4r4:***.*:tr4:*yz;:*:y::4=t.*:4:**i:y-4"4-4:y'***y:*y::|:y:***:**:*****:4::4:y'***:y"4:**:**:*i:*i:*:4:*:*:*:t:H:*:*****i:*M:**:
S0Î.9CE 0" DEGREES OF SUM OF MEAN
VARIATION FkEEDîOM SQUARES SQUARE F-RATIO
* 4::4:**:4:**i4:**:4:*:4.i:i;*.-4:)|::4:'4:*i:iT*:*i:y:*4:y::4:i::4:**i:***i:i:********* ili:#:*:*.*******;*.**.* 4-4:*:»:*:*****r4.*
BETWEEN 1 79194760.2 79194760.3 21.5847886
WITHIN 5 18345039. 6 3669807. 93
***i:***y::(:*:*:***:***r.4;**:*:***;:4r+:*.*r4:*:'4y4;:t:***:*,**:**y:'t:**?»:*A*y-y:*4n(:****:****.****:**;4:*yT****;'4:*y;**
TOTAL 6 97539799. 9
***:***r*:.**:.-4:*:*:*.**::4:.**::4:*:**:******-*:**:*:*4:**:*:*:**:***4:**:**:***=4:**r434:**r4:*4:i:***i:*:*r.4:***:**.*:4::4:*:4r4:
MYOCYTE VS NON-MYOCYTE 3.H ACETYIATION 50 DAY H2A+2E 
ONE-WAY 'ANOVA' TABLE (RANDOM BLOCK DESIGN)
*;**.** ****-**'4r4:*y:*y:y:**** 4:**.4:*y:*:y::4:***:*:4;y:*****.'4:**:4:**:4:*:4L4r4:******:4:*:'4.:4 *'*:*:4:******r4:*T* *:.*-**
SOURCE CF DEGREES OF SUM OF ■ MEAN
VA='IATION FREEC'OM SQUARES SQUARE F-RATIO
:4 4:.4:*:**:4-*:4-*'*:*:*"4:*:**'* '4 *** 4 i **:*:***:***:**:*:*:*:** ***:*****:*'***:******"**** *:i:***:**y:*:*:****'t:***
B ETWEE'-; 1 767828.973 767828.973 31 4993784
WITHIN 5 121878 75 24375.75
*:*..4-4r:4'*.4:*:.»::4:*:4t **.*:* ***;** ****:4;-*'4-******y**-4:'4:**-******::4'*:********+"t:***:.4:*:**-**.-4:*--**;.**:*****:*
TOTAL 6 889699.723
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^  Tnii
K<i>T£ UON-nVOCYTE 3r: FIETYLATION 50 DRV K4 
CNE-WRV 'P.Nj'/A' Th-LE :R.R!,:{": t.iCK [ESIÜN)
* ' * * +  » *  » *  y  y - y  * * y  y - y  ri y  y i  jT ^ ^ r y - y r r * * ^ :  * * : : »  y : y : * * * y : y  x y - * . * * y : y  y  y: * y , *
io:j- : e c; degrees of sum of merh
•’-.r.ri'T, FREEDOM SQURFES SQUARE F-PATIO
BETWEEN 1 47457224. S 47457224.8 S. 76291952
W!‘ 4:n 5 27079425 5 5415687. 1
-g g 4:4:y "4:g:'4:T4:i:g 4
TOT-L 6 74525660.3
yy.y y»:y y-.y:y y » y:y-:(:*y:y**y:y:y:* .y;*y y:y:y:y*y-y:y:y y;*y:y:y:*y *y y *y:y y:»!y-*r*:*.-*r***;y:y:*:y;'t.-y;y-.*:*y(**:*:y;yS'y-*y-yyy:
r-T'jU--E vs N'N-MYOv-E 3H -GETYLRTION 100 DA'-' HI 
ONE-WAY •••fiN'O'.'A/ TABLE (FA'JDOM BLOCK DESIGN)
;yy.y;:l-y -’ y:*y **. ' y f.y:*::'' y:y:y:y:int..y:y:yTy:*y;:*y-y\y.y * * * *
SO.PCE OF DEGREES OF SUM OF FEAN
V--:"!ON FREEDOM SO’JA^ 'ES SQUARE F-RRTIO
.  .  v , y y g . .  -  g- g -^ .g-v ;: i-g * ii:g -g ; ;4 -> ” 4;j4:g::4;» g -g r^  g  g :g :4 T g .'*  4: 4Ty.:4:g g :g 'g :g  y 'g ::4 ;g :g :
"OTA. 5 77050725 4
-  > : i- • ;j ! •> •• . •  i a  g -g  ^ ; 4" S 4 '4  t -g  » a - g j - i - a - g  g ;4 * 4  * " 4 '4 '4 ;
MYOCYTE VS NON-MYCCTE 3H ACETYLATION 100 DAY H10 
0NE-;FV '^ NOVû.- TABLE (RANDOM ElOCK DESIGN)
y:y:y; » y:y:y.y:y-y«:>: *:f:S-.y:y ■•:y:y:y;y:.*y:y:y y:y:y;y:i:y:.»: ' y:y:y:>:y:*y:;f*r-t:*.y:y:y:y:y:*:*-y:y:*y:*:y:ÿ:*y:y:*:y:*y:.yui:iai:*;*:y:y;*>f;y:*;*
SO.FCE CF DEGREES CF SUM DR MEA'i
-'A-IA-'N FREEDOM ST.'ARES SQUARE F-RATIO
BETWEEN 1 141542594 1^ 1542694 649. 00Û615
WITHIN 4 9720:72 25 219092.313
y:y:';"-"- '- t.y:**J:y:*y-y:.t:*y-y"y:i .;■■»•*:*•. y ys-^yy-y: ». y*;y::4:*:*:*:.i:Ji:y:*:*:*:y:y:**.*;*y->J:y:*y:y;**:*y.-.:y:;4;y:>(:y:y;y;y:**y:y:y:*y:y:
TOTAL 5 142415057
M'-'OC'-" 'F. NÇN-HVOCYTE 3H ACETYLATION 103 D=V H3
ONE-WAY "ANC'V'A" TABLE (RANDOM BLOCK DESIGN"'
SC;.-CE CF 'EGAEES OF SUM OF MER'J
V-TAT'CN FREEDOM SC'UARES SOURRE F-FATIO
f:g gT"*S:g:4y4'ytL4.g::4:g'g:g:g:g:4Tg:4:g g:4:4:g g:4:g:>:g:gTg:4:y :4:g:4T:4;'4:g:gT:4:g:4;)}T:4n*:)k:4:t:4:4:g:x
BETWEEN 1 146421600 146421600 30. 9376962
;UTb-'.! 4 1;'?92552. 4 i ' ’49128 34
•A::*”. g -i •.• i w a-v-vg-.-^ tafi'arga >-à'à'g:y:g:g g;gr *-g:'*:g;;i.g g g: g g-u g-gTiig.-*:a g * f  •• - t * :f •* >'.> •*••••
N:'-RL 5 165'p 14154
y •»•• ■ 4 i a-a .'••••;* 4 •* 4“* .• 4'^ . - .'-j-a y .  ■•' * . j- y .". L;a 4;^. g. *' *"'* v*;g;g;g;-i/«*-|-g'g;a'*i;g-a*g”i-i;
153
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TE non-mvccvte gh p'etvlht'O'j i% if.\ -i-p-is 
TABLE 'RANDOM ElOCK DESIGN':'
SOURCE Or DEGREES OR SUM OF MEAN
'-'ARIATION FREEDOM SOUA-ES SQUARE . F-RATIO
E'ETL'EEN 1 2446092,5 2446093.5 18.5724474
WrniN 4 52?'22. 00? 131705 502
TC’ AL 5 2972915. 51
MrlCVTE VS UOÎ-J-MVOCVTE 3H RCETVLc-'oit 160 DAV K4
ONE-WAY "ANOVA' TABLE •:RANDOM BLOCK DESIGN)
SCliROE OF DEGREES OF SUM OF MEAN
VRRIATION FREEDOM SQUARES SQUF’ E F-RATIO
BE-LEEN 1 392192. 913 392192 913 . 0?6‘ 41=-2S
WITHIN 4 1628:43: 3 4070358.33
TQT-. 5 '16675626. 1
- a  g;;*':;r>;a-4;g: g-i-g-:-; >» * .g*v--'a:a-*-• •♦•vr*vya:a:Y>-4;g::4;.-4::4::t:g;>4:;4::4 ?f:g:54;:*::^ ::4:g-.:4:;4:a:a:à::4;a:a--.:gr'*”..;a”>,'4->;>t:*:;4;:V.g;-4:
MYO'CVTE 3M ACETYLATION Hi 21 50 130 DAYS 
ONE-:.fY "ANOVA" TABLE (RANDOM ELOCK DESIGN)
SOURCE OF DEGREES OF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE F-RATJO
BETWEEN 2 3955?:?10 19779435 3.99222292
WITHIN 7 35572432 5081776
TOTAL 9 75131242
MYOCYTE 3H ACETYLATION HIS 21 53 133 DAYS 
ONE-WAY "ANOVA" TABLE (RANDOM ElOCK DESIGN)
SOURCE OF DECREES OF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE F-RATIO
BETWEEN 2 859138.469 429554.234 1.39568871
WITHIN 7 '2154435, 66 3'07772. 237
■i..*..i..4.a..».-i.g..»v4:grA;>|“A:‘4;:4:‘4;a*:i*»a;:4:'W"<r*'g-a a  f’^ * 4::f:'4:'4ra;:f:'4.-4“k:
Tij-^ AL 9 3313514 13
' * " 4 ! :+ * '4 'a - i " g * a 'a . : i ; 'f i :g : :4 : '* :a - : * ;g  •#•■*••••-» * a ;a -  i - 4 ” .':a * ;4 'a f4 rg :g :;4 ;a ;;|:-4 ” 4*-4r4r;i*«4t4rA'j4*g*«**g” 4*«4r'f"+;:4.“* : -4 'a ! * * - a - ^ a ” *-*« * irg - ^ -4 ::4 'g  "4 g T a-a -g -4 ::4
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M'-'OCYTE HISTONE 1
ONE-WAV -pNOVA" TABLE -'RANDOM Bl CCK DESIGN)
SO'IFCE OF DEGREES 0  ^ SUM Cf MEAN
'.•‘BFIhTION FREEDOM SQUARES SQUARE F-RATIO
BE'NEEN 2 S 49664164 4,24832082 3 22121101
WITHIN 7 9.23200798 1 . 31S85S2S
TOT^L ■? 17. 7286496
■Jvi. » yy . y y.y y. kY:*:*:* *'**!:** i r i *:****** i y t**y.y:*.y:y***:xy *:**rt:*:*:***.y:*.*.y:*y:y:***Y:*Y:*:****-***
MtOC'TE HISTONE KiO
ONE-I.-Y "ANO'-'A" TABLE (RANDOM BLOCK DESIGN) '
.  a  ; . i > - i - - . t f N , ; a : g > ; g - a : : 4 . g - a - ;  - -  : 4 - .  N-" 4  a ; y : i  . g : g . a  *• •  >. • * ; > ’t:;*:g:Hw+;J^"f-H;;J::4::4;:4;:4::4;
SO FCE 0“ DEGREES OF SuF j r  MEAN
VARiAT;O'j FREEDOM SQUARES SQUARE F-PATIO
g;;4;> a •.-•:4::4::4:g:a:g:,•'•;■* ■'■; :4.:4;.-:S. i *;a:g:g;>>;:4;g;*4::4*>:>i;;i:g:g:a:y:^;>f;g::^r-^:g:;4::fra::*:>.;4:.4::4-.
BETWEEN 2 - .  2 65189 2l6 32594.5 86. 713358?
LIT-:': 7 17.4630:'18 2.4?i*’2455
y  y . ,  .» . y . y . " . 4 : * : . , : : y * ' . y : y . y : « »■*■»::»:*»■■»■» .  . . y  y . y  . y : * * y : : 4 . : i y : : 4 : y : * * * * * ! 4 ; * * : 4 : * ! 4 r 4 : * ^ ' * * : 4 : : { : * : 4 : : * * * ^
TOTAL 9 450 114962
MYOCYTE HISTONE H3
ONE-WAY • ANOVA" TRRl.E "RANDOM BLOCK DESIGN)
y:*y:y::*.):.y:y;-.4-y:*:**;**:**:*y;*y:*:y-:»:!t:*y:*y:*::t:*:*:*:*y:y:y.*..»yy:y:*y::(-;*y:y:y:y-*y:*y:y;.y:***y;.*;4:.y:y:*:<i****.**>(;y:***>:*:*
SO :;-:E O' DEGREES OF SL" OF MEAN
•.'A=I:':I0U RRREFAM Si'L-ARRS SO-UAAE R-RR-'O
• A. V:4.>:>;g-a ’4:g;:4:>|‘:4'*4:î*::4-a-a;v' i A-g-i;
BETWEEN 2 3619.70295 1809.85148 463.3075
WI-y:n 7 27.3446045 3 90637207
TOTAL 9 3647.04756
gyjT':"* a-giM >4:g;g 4;àM4i:4:gr4:a;gx4rg a:g':4:'4:*}4:A:4:4:g:4:4:g:g a'g:;4;ay4;g:g:': a/f':4:y:4:4;:t:;f:i:H:f:a:4":4: 4:4:4:MT:4T:4:;4:4:4:X:4-'K:+:f:M:*i'
MrCCYTE HISTONE H2A+2B
CNE-L'RY ' ANCVR" TABLE (RANDOM BLOCK DESIGN)
g/fTziTiif ^:*-^M^'M:7f'iT4'i:4M4'X-"4:gr 4:4:;4':4:g )t:g:4:4ra:4:g:4:g: 4*:4.:4:4':4;:4:î}r*4:>J:a:a:4rg:4'a‘*^:a*g-a;-i;:4*y4n*:f:r4:;f.H:g*tg*a:4*a-4*r4-'>^:H;:*:^.'1:H;^‘îf*‘*:^'îf:>*'
SOURCE OF , DEGREES QR SL'M MEAN
VARIATION FFEEDO" SQUARES SOURRE F-PATIO
;4-g-;i;-i'a;g-a:4*g:4; f-grtf -:4'4T4:a ;g a-a;a * g 4«4;4:g:*g,4 a . a arg;g :4"4:S:a:g;4:g'4':4:4:4'^;4:)4:grg.yr:4:i:y:4:
'TEU 2 2000 59Rr- 1000 29906 488 287523
7 14 2 oRSFSfis
■J '*•, . .••*•' ■ • •. . '* i-g •. •*• a- a, a V •. ■!• • •• g' -i"! 4i '♦■■•’• ■** a -4' • j; *-a , a •-• *•■••»••* ■ f- « ' • a • ; g j •;/••.;•*••*• : g*a-a; 'A-g; •• tI.* S' a a'
. . . . . i i -i -i -t 4 ••• ■ •. i‘. à . . . . j à . 'J * ; . i . ! 4 -I •• i . «"i"* . -i' i'-.- * i 1 - • .
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MYOCYTE HIS'C.'E Y4
C'.'E-WPY ■■PNOVP" -ABLE CPA'.'DOM E'L'nC" DESIGN)
SOURCE OF DEGREES OF SUM CP MEAN
VARIATION FREED:!" SQUARES SQUARE * F-PRTIO
BETWEEN 2 72.4861492 2b 2420747 20.8:.93022
WITHIN 7 8. 22-149968 i. 17449955
TOTAL 9 80. 707649
l.Of.'-MYOCVTE HISTONE HI
ONE-WAY '•R^ tOVA" TABLE (RANDOM BLOCK DESIGN)
y : . .  y : y : y x * * * y : * * y : * * * : * * . y : * * * . * . * * . * * . * . * y : * y : . y : y : * * y . * y : * * y  y . S ' * * y  y : * * * y : y : * * y y : * y : * y : * y : * y : y T y . y : * * y : * * y : . * y : y : * * * *
SOURCE OF DEGREES OF SUM 0- MEAN
VARIATION FREEDOM SQUARES SQUARE F-RATIO
2 C94 :<Bj:f- 147 .:^7.:.4 20. 625:128
WITHIN 6 42 8329291 7.138988:8
T, - , T f i  O  T - ' T  - ' Z i O T O i :
r.'ON-MVOCVTE HISTONE HiO
ONE-NRY "ANOVA" T.ABLE (RANDOM BLOCK DESIGN)
SOURCE OF DEGREES OF SUM OF MEAN
VARIATION :^EED-OM SQUARES SQUARE F-PPTIO
BETWEEN 1 6. 6.6379929E-G5 6. 66379929E-05 4. 59044731S-04
NITHCJ 4 .580666661 .145166665
TOTAL 5 .580733-299
f:ON-MVOCYTE HISTONE H3
0*.'E-WfiV "ANOVA" TABLE (RANDOM BLOCK DESIGN)
SOURCE OF DEGREES OF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE F-RATIO
EETLEEN 2 33.010067 16 5050325 2. 45227882
.::Th:n 6 40 3829288 6.73048814
TOTAL 8 -^ 3 3929959
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
•AN;>.A- TABLE (FrNDOM FLO'-.-
*  y * * / y y  y  * * * y  * * y + y . T ,4 y  » y Y * y . y  y - y  ' • y >  y : y -y -v .y ;y -y : y : y : : r .y : y - .+ : y y  y :  ' f » * y : y : y  y r y r y r y ^  :* ' : * y : y : y . * * y : y : y : * y  y r y . y : * * *
EC.F'E OF ['EGREES 0  ^ SUM OF MEAN
VARIATION FPEEDOM SGUA:'ES SO.UARE F-RATIO
i a. . g-.* a-a g/f a a a a a-4 a a a a a a'a a-a-varg:4r>Jr}|':4-.:g;:4:t4;:4:H:)f:i:4~t:i*;*‘)tMf.:4:g:)f:g-a:>f:)t'>4:
BETWEEN 2 554 781258 277.390629 43 3923133
WITHIN 6 39.3557282 6 39262135
y:y;y»:y..*y-y:*y-y:y:yy4-yry*yry:y-y:yy'y-y:y:y-y-y:y:y.-;*ytyy y»:y;y:y;y:y:y;yr4Y>iy;yr4:y:yy»:.y;*y-y:yry:y;y:y:y’yr*yy-y-*y;*y-y-y:y:yy:*y”4:y
T'-tal 8 592 136986
y;y:y-y;yy;-*y:>I:y:y:y:y:»:*y;yy-:f'y:y:y'y;yy:*<;y:y:y:.+ y:y;y:y:y:yr4;yry;y;y:yr4-y:yfJ:y;y:y;y;y:y:y:y;y;y;y:y:y:y:y;y;:f:y;y:y:y:y;y;y:yty:y-(:y:y:yr4:.y;
N’ N-U'TijCVTE HI6.-0NE H4
3NE- P ( R'KTR='..E (FA'.'DCM ElOOK DtSIO'!''
a - >  Ÿ - . - a - a - a - a  a ' a i a  ^  a . g - a f .  -.: a * > â 'g -a :a ;g ;j.;> ;g .g .;A -a :g *y |;a ;a ;a  a ; ; i ; g  -« a ra  t ;a  g  a  a  *
SOVR'iE OR DESFEES 0  ^ SUM OF MEAN
VARIATION FREEDOM SO.AFF? SQUARE F-RATIO
g .g  a  a  a  a y , - .  a -a W T g S : a ; g : a : g :g ; '* 'a  . y . ' a . a  a a :a % a 'g  a  a  a  a
EE'VEEN 2 124 783489 62 3G."-45 12 6291981
6 28 64:6657 4, 94037762
•. V  . i a  . : < - g ; a ; g - * : a - a  :  t -g  . g  a : - * - .  •. a -> ;  ; -a y . a a  a ;s ,: :g ;g :g y .; .» ;a x ^ ;a ;g x ^ : - * ;a x .y ,:g ;^ ; :^ ; * ^ ; : ,;^ ;y ;g ;^ ;a ;a :g :g 'a 'y :* a 'a ; )^ :g :a  . : ÿ : g  .  a y i y j ; * : ! ;
TO-al 8 : 54.423155
i - a  •■» V a  >  a a  \  -  -  *-a ;> i a  g* f a - i y f a i a - a  ; a -a :a 'a 'a ;a y i , '^ ;g ;a ;g y .^ ;A ;> ;g -g -a -g ,a ,g :g -  i ”-:a ':A ;g :g ;,'|y *;g y .i;'. : - j 'a : g :a  ,f;a ;
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■:"“L HEART HISTWE Hi lE’üTÎON
0':E-L-V ■c;,?VA" TABLE CRAN'OM ELOC" DESIGN)
SOLACE i'R DEGREES OF SUM OF MEAN
VARIATION FPEEDO'1 SQUARES SQUARE • F-RATIO
BETWEEN 2 47.591074 22.79552:7 2. 8992899
WITHIN 12 9S. 4850102 8.26708418
TOTAL 14 146,076084
TC'TRL '■EA-T HISTONE H10 N DISTRIBUTION 
ONE-WAY 'A'iOVA-' TABLE (R-;[.;;« d^ qoK DESIGN)
g 4'g-:4:)*"^ :!i'i:a'4T4:4r4:4;4:4:Y:^ r4:y:g a:g'g ^ a;g;:^T4z*:4i4':'Tg:< 4 a-g 4:4:g:4;-.:g:g 4:4:g'g'a'aT4'4:'*:'*':f:
SOURCE OR DECREES OF SU" OR MEAN
VAFIA-'CN FREEDOM SQUARES SQUARE R-FATIC
4:a;:):4:g:ay*; g 4:4:*a:*'.:4r.^ .g:Ÿa:-;:4'a'a;g'arg argra a^a;g:ayiy^;4;gTg;g-t;*.^g;g:gxt:4N+::4:)#:4'4:4 4".
BE‘ NEEN 2 1 02475795 . 61228397? 1 65479402
u r n  IN 12 4. 440?K;25 .370066521
. a a ;.:a;g-i a;:i;*|:a >4:g; i:g:>;4:a;4r:4:a,4-'*-A::ir>;.4;a'.a:4:.4;:f:}):.a-4::itg:'Aa-;4rrf.4*4:A:^;4r4:4:4:g:;^;a:a-:4:a:a'g«4::^:;i:?{;x:4:.-t:4:4:4:4:4::a:;+::f:
TOTAL 14 5 66556621
TOTAL HEART HISTONE HO % DISTRIBUTION 
CNE-LAY "ANOVA" TABLE (RANDOM BLOCK DESIGN)
* : * y : y  .*;** *  s : y : y x * * * % t : * * * . i r »  y:*y.*.*y:*y:.*y:»:*.y:y:y:*y y y - * * * y  4 : y , y : y r ^ . y : y : * y : y 3 t : * : * : y : y - * : * * y : * * * * y : * * * : * * * * * : * * * * *  '
SOURCE OF DEC; EES OR SU'M OF MEAN
YARIATICN FREEDOM SOU AF ES SOUAF'E F-RATIO
*:*:/y:***:y:*yy'**y* *».y*ç:*yy.'**:y:**y:y:y'*yvy:y%yy**yy;y;y'y:y y;y:*y:**yr»:y:*y:*y:*y:y;***y y:**y:y;*y.***y:**y:
BETWEEN 2 59.7833996 29.8916998 3.60380905
WITHIN 12 99.5326857 8. 29447382
TOTAL 14 159.317085
*:**y..*y:y:y:y::t:y:*y:**y:y:y:*r4:;*r4:y:yry::4:*!(:*yry:y:*:y.-y;yr(:ya4:.y:y:y;*yy:y:y:y:-t:y:*:».Tt;y.**y;y:v"'yv4:y;*:4:y;y;y;yrt-y’.**r*y:*;*:y;*y:
TOTAL HEART HISTONE H2A*2B ’/. DISTRIBUTION 
ONE-WAY "R'JOVfl" TABLE (RANDOM BLOCK DESIGN)
* * * « : *  :4 : :4 : * y  •  * * y r *  y : y : * : y r * *  .  * * * y : y : . * y : y : * y : * y : * y : . * * * y : y y r y ' * . * y : y : y : y : y : y y * y : y : y : y : y : *  4 . . \ : ! i : Y * y : y : y * * y : * * y : y y y . y : y : * * y :
SOURCE OF DEGREES OF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE F-RATIO
BETWEEN 2 121.099487 60.549743? 7.65037195
WITHIN 12 94.9753723 7.91461406
J!5»;:tra:g:a-ar-f;a •- a a- a:
TOTAi. 14 216.07486
■• •:.4 '4:'». :"4 » 4: 4.:********:y*'*:* 44^ 4:****:*z4%4::4::4 y:**T»:.i iry»:y i-»'**:**'».*:**.***^ :** y:*.*.**:*:**:***:*:* » *** »:y ••■*
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TvT-u HEP" HISTONE H4 % DISTRIBUTION
O-.E-.-AV 'Rr.OVH ■ TABLE CRPnM'M BLOCK DESIGN)
S:.. --CE OF DEGREES OF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE F-RATIO
BETWEEN 2 91.3668252 45.6834102 6.14253618
WITHIN 12 89.2466736 7:4372228
y.y, y yyy:** * y y-y y- ' *y*y: t *y .» *:':y:***.*yy:y:*:y ***y:*.y:y:*ir****y:*:***i *:**:*:*:y:**y*:y*********
TOTAL 14  ^ ISO. 613494
*:/:* yy:*:»/#.**:*:*:*.*:*:*. 4 *-» y:**:**.* * y:*y:y:*y:yTy:yry:*.y.y:y:y:y:y:y:y:y:y:y.y:y:**y.y34:**.y:y:y:y:y'y;*y:y:yry:y:y:*:y:y:y:**:***
1 5 7
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’"-DCY'TE FvLv«ç?cr- û- ttvjtv 
C.T-WAY "ANOVA" TABLE (RANDOM BLOCK DESIGN)
y-4:*:yT*:**yrky:y:*y yiy?» y:****y:y:y***y:*****y:*y:y:**y:**y ***y-***y:y:***y:*yr*y:*y
SOU-GE 0" i'EGBEES OF ■ SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE * F-RATIO
BETWEEN 2 155795. 607 77899. 8037 2. 28024836
WITHIN 5 118740.71 23748.142
TOTAL 7 274540.317
****y:*y:*y.y-**y *_y:*y:4:.y:*yy *y-y:y y:*y:y:*y:.4 *:M **:4:y:**y:y:y:y:**y.*y:y:**y:*y:y:.****y:*
NON-MYOCYTE PNA POLYMERASE ACTIVITY
ONE-WAY -ANOVA" ThBlE (RANDOM BLOCK DESIGN)
S'CJRCE OF DEG-'EES OF SUM OF MEAN
VARIATION FREEDOM SQUARES SQUARE F-RATIO
BETWEEN 2 2387828.79 1193914 4 701. 357881
WITHIN 5 8511 44922 1702 28984
:<:aMi‘a:a-4:a*a'>v*i*arg'g*>f;;r a*** .-a ay: a a'a*a:g;g:ay4*gS:^ ;a:Ÿ>'a.a*a*g:gyj;a;a*g«a*ay::a-**-a:>i;g;gyi:a'g*a'ay4-a:a-;f
TOTAL 7 2396340 24
TABLE OF "Q": MYOCYTE PNA POLYMERASE ACTIVITY
2 1 3 0 0 0
i. 13069062 3.78882513 0 0 0
0 2. 65813451 0 0 0
0 0 0 0 0
TABLE OF "Q"; NON-MYOCYTE RNA POLYMERASE ACTIVITY
2 3 1 0 0 0
-6.09971422 43.4620381 0 0 0
0 49.5617523 6 0 0
0 0 0 0 0
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-:":L  PTv'-'MEPhgE PCTIVÎTV
rfJE-WAV ''A'.'j'-'A'- TABLE (F:A\'50M BLOCK OEZIGH)
EOV'lE C“ DECREES OF SUM 0" MEAN
'.'ABTATIOU FREEDOM SO'UARES SQUARE F-RP.TIO
EiET:EEH 2 1?^ SB22 21 973411, IGS 29.7040589
WITHIN 5 163851 531 32770. 3063
TOTAL, 7 2110673.74
1
•^ AE'lE of 'O'- TOT'::! F'N: F-jLVMERASE ACTIvjTV
2 3 1 0 0 0
1 585^ 2213 16 6176399 O • 0 0
0 9 03221778 0 ■ 0 0
0 6 0 0 0
1 5 9
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TABLE OF '0/ : TOTAL HEA-T HISTONE Hi % DISTRIEHTION
1 2 2 0 j 8
-  203481447 1.5"851083 0 8 8
0 1. 77331223 8 8 0
8 0 8 0 8
•*: * • .  •*::{ ;4
TABLE OF -O' ; TOTAL E^AFT HI STONE H18 % DISTRIBUTION
1 2  1 0  8 8
1 3:330305 2.18428784 6 C j
0 . 16:13333 8 8 8
0 0 0 8 0
TABLE OF "O' : TOTAL HEART HI STONE HI % DISTRIBUTION
2 3 1 0 0 0
. 451589667 2.89E{i4486 8 0 8
0 • 2.64653539 0 8 0
0 0 0 0 8
TABLE OF 'Q': TOTAL HEART HISTONE H2A+2B IT'ISTRIBUTION
1 3 2 8 8 0
3 8253:1556 4 52982252 0 0 0
. 0 . 70400696 0 0 0
0 0 8 0 0
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-:=LE CE -çy . -:j-RL HER:: HISTONE H: % pISTRIDUTION
2 3 1 0  0 0
3.45353956 3 47553663 0 0 0
0 ,0219970681 0 0 0
0 0 0 0 0
.61
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■.f**-* 4 /^4"'*4"4:*v*!4':4 4:4"4:4:*:4':4.*4:'^ :4:*:4:K':4:*;4.i4:i'4'4 4:4%
1 3 2 0 0 0
N ?» '4:;* :4: 4'4:?*'4':4:4 +'4:)'f:*+4:'4:*?4"4y:?4:>4-W'4:'4:4r:4:4:4 ?4:4-y:4 4:!4:?4:*?4:?4:.t:4:'^ :4T?4:>4T:4::4:**:4?***4:?4:*t'4'?4:*:4:'4'?4??4:*:*:4::4:*y:4:+*+*:4:*
6.60519594 8.70537601 8 * 8  8
0 Z 18018005 0 * 0  0
0 0 8 0 0
)l;:4:4:?l.!4;4:*4?!4:4 .4 4:?4:H:v4 *?4:.4::4:?4::4:*4:?44:^:4:S.-4:*4::4::4"4:*4:?4:4:4:!4:t:4:**+4:+*!4::4*:4?*W:*W:t4:4T4::4:4:)4:*"4::4:*4:?4:\4::4:*.4::4
TABLE OF 'Q': NON-MYOCYTE HISTONE H.10
:«- I + 4 : : ' ? i ? : *  *S:'4:4:4:?4:?4"4:?4:**'*?«*!4:)!'i?4T4:*;4Tt*4:;4.4:4.**'4:?4"4-?4:!4:*4:f?4:*Ÿ*:4:'4:y:1::4:44:**:4:!4:?4:*M:'4::4:?4::4*?4:j:?4:
1 2 3 0 0 0
4:i?4:*?4:*i:*i**:4*M:4:4:*^:)4:4:?4:$':4:4:!4T:4:X:+:4:*.4'?4:4:4:4:4:+*:4:y:4*4:*:4-4?)4:'l:S:?434?:4:*?4:4:*!4:?4:4:'4r4'!4?!4:!'.4';i'S')l'?4:''<4'*!i:4:W:*:4*'4:+'4:!4:)4:*i4r^:+'4?4;i4:!4:*
21.5603084 21.6057943 0 0 8
8 .8454858816 8 0 0
O ' 0 0 0
TAB'.E ÎE 'O': NON-MVOCVTE HISTONE H3
1 2 3 0 0 0
. 292768868 Z 84421677 0 0 0
8 2.55044791 0 8 0
0 0 0 0 0
:4-4.*!4:?4::4:4:4:i:4.':4;*'4;4."4"4'.i"4"4"4"4::4"4:4:4?4:*-4:M"4:'4:t4:+:4:?4:*:4:'4:4:+*4:*M"4"4:*:4::4:i4:4:4:4:+*?4:T4?:4:4:+M:4:4:4?*:4:*:4':4:?4r*!t:4.:4:V:4'4:i:?4:*S.4 ?4.-!4:*4:**?4:*?4:*
TABLE OF 'O': 'JON-MYOCVTE HISTONE H2A+2B
?4.-?4:.*;4:?4;=4‘?4:^:4;:4:4:4?*:4:H:4:+1:>4:?4?4?+?4:»?.^:î4^+H:!4:.4?:4:4:4:+î*?î4:?*'’4:!4:'4?4:'4:4;?i:!»;:4:Mr^:?4’'4;+.'4î?4:4:i:.'4:^:4?4:?4.'?'.;4:?4:?f:4:54.’?4:^:?4:4:^:?4:^?»:!4:?4?*4?4'4?4:4;:4:*’4?:4?4.'?4;+'4?i4?4’*:4'4’'4:
2 3 1 0 0 0
.ir4:»4::|:.i:$?4:4:4:4:M:H:4:*.'4:$:4:*:4:4:'4:$:4:4:*:4:i:4':4:$*:4:M:4:.'4:4:4:4:*+:4:4:4:)4:4:4:?4:#:$:!:*M:4:+*'4:*!:?4:*'4:M:M4:4:4:+:4:H:$'l"4."4:4:!t:?4:*"4:4:*:4:4:!4"4:4:+*:4:'4Xf:
-4. 28242943 8.65393341 8 0 0
8 12.9363628 0 0 0
0 8 8 8 8
,4.“4:+:4=4"4?54:H;)4;:f!4.’f:t+*>*-4!:4:!t:fc4-T:Jt:?i:++’4:4;^?!4::4:4'4:+^-'4^.+'^"434>f.“4:4:4:!4:'*!:+:’4:!f.!4:^:’4^;4=t’1?!4:’4:.+!4:>4:4:i4:H:^:?("4?H.'.4:.1?:4;:4:?4:4.!4'.4:4:?4:J4:!4'4:j4~i:!4'
TABLE OF 'O': NOf.'-MVOCYTE HISTONE H4
?4:*:y::4::4:*+4:!4:W"4*4=4::4:'4:**'4?4.:4:?4::t4!:4::4:**!44:4:**4':4:'4::4:i:.4:M:4:*?4:4-'4:y:**H:*+.4?+:4:'44:*:4=4:*4"4:?4:*?'::4':4:*:4:'4:*W:*++^'Tt'4;#:+4:+4:t:*!|:?4':4'.*?4:'4:4:
2 3 1 0 0 0
**:4x4:.*.4:.tt*:4:'4:''.**?4:**:4.':4::4?:4:'4-4:*Y4?i:*?4::4::4"4:t :4:****W:+**?4:.'4:+'4:*W:'4:*:4::4'.:|:$:4::4:*:':4::4:H.:4:4:#:$4::t:^:$M::4=4::4::4:.4:.'4:i.:4::4'?4:*'4:?4:+**4:W:i:?4:!4:!4:*
4.41076159 7.02916423 0 8 0
0 2 61848264 0 0 8
0 8 0 0 . 0
* Y4 'rT$4::4^ *'4 Y.?4-4:?4T?|.>.4y4:?t'?4:.4T;4'y:4:4:y?4*4.*$+*:4:4 +?4*!4:4:4:4;*i:.fy:.4:.+?4:i.T4:4:4:.ir4r4:?!r4':4S.?4.T{:ti"4:i:4:?4:+*)4:$^:)4 :4
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-RE.E CE ■C": MYOCYTE HISTONE HI
1 2 :< 0 8 0
1 78569278 2 601652:56 8 0 0
0 1.81595978 0 0 0
0 0 8 0 0
TABLE OF 'O' : MYOCYTE HISTONE H10
1 2 2 0 0 0
11 8655165 17.2988474 0 0 0
0 5. ■^ 2222087 0 0 0
0 0 0 0 0
T-BLE Cf 'O': MVOCYTE HISTONE H2
2 2 1 0 6 0
4' 4 ?444'.i4??i444 i44:$?*44::t4??i44 ?i44 Ÿ:4 .i444444::+4x44.4:.44444:*
-1.25419297 35 9944611 8 0 0
0 37.2486541 0 0 0
0 0 0 0 0
TABLE OF 'G'; MYOCYTE HISTONE H2fi+2B
S:W4:#4444::f444444::t:M44:*:4::4"4:**W'f*:+4.;t.4.444:$W
1 2 3 0 0 0
26 5212:489 38.335924 0 0 0
8 1 81457512 0 0 0
0 0 8 0 0
TABLE OF 'O' : KVOO'tTE HISTONE H4
2 3 1 0 0 0
6.28911334 10 2482018 0 0 8
0 3 8590885 0 0 0
0 0 0 0 0
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L- "I ' : Eôi'V
4- ^ 4 ^ 4;-»-4-4 ■<• 4 4' . * * 4'4 4 -i- • * y 4"^'4 4 4 4 > 4y4> '^"*'4' • * -4 4 v 4'4 4'4'4;'4" 4-4 4 -4 4-v 4 -^;'4'4'4 4 4'4'4*'4;;4 v 4' ♦;
1 2 2 0 0 0
10 3569]44 29.1091313 0 " 0 0
0 18.7521969 0 ' 6 0
0 0 0 0 0
TABLE 0F 'Q'- HEART WEIGHT
1 2 3 0 0 0
13. 6423601 27 091759 0 0 0
0 13.4493989 0 0 0
0 0 0 0 0
■^4:4:4'4:4‘4:4;;4')f:>f;4:4:;*;4-*- * *-*:Vri;4**;4*4'y**4:}f:4:;4:4'4'4;y'4''4:4'4'4;*y:4:?4;)jxi%l;^ 4:4::{;*)l.yTr4:C;4:Ti:4r'4'4*4'4r4/r4-:f'4.^ '4 4:4*4'4T'4:4x4'::.)t 4 4%i:4'x:4'4 '4':4**>}:4*y;4:4:*:):>(:**
TABLE OF '9.'-. TOTAL DNR Ulj:'
'4r4'4'4*'4-4r4:4TT4'4T*4T4:'k4N;!4'y'4Ty*4:;4y4r4'4'4.4T4:;f:y-'4'4''4:yT*;4:r4:*4:yry:*:i',4::4x4:W-:4:4x4*-4:*4':4::i::4:T4:)4:y::4:r4ry::4;)4:y;:4:y:;4::4:;4;);:;4:fx4;;4'^ :'4-4r**^
1 2 , 3  0 0 0
416124739 .66415265 0 0 0
0 .248027911 0 0 0
0 0 0 0 0
TABLE OF '9/ : D'.'A CONCENTRATION (VI GRA1M>
2 : 1 0  ;• 0
-10.3791004 17.5242673 0 0 0
0 27.9033677 0 8 0
0 0 8 0 0
TABLE OF '9'\ TOTAL RNA (MG)
1 2 3 0 0 0
7.68160753 12.0185652 0 0 0
0 4.33695763 8 8 0
6 0 0 0 0
}J”f t 4"^ r^ x^ x4:4 '<'4;yy^.;^Ty:t4"4"4x4"4 4 :i i 4 -j;4 4*-f'4-i-i 4-4:4:4:4",:4r4*4:4r4'4*'<^:4;;4;:f*rf4'4:4V:îf;4-:4;'^;ii::i‘:i*>*:M"4-
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'ABLE ijF -Û": Pfp CONCENTRATION ' MO. GRAM-1)
2 3 1 0  0 0
-7.55148029 18 1044961 0 0 0
0 25 6559043 0 0 0
0 0 0 0 0
TABLE OF 'Q': TOTAL PROTEIN ':MG)
1 2 3 0 0 0
15. £663991 23.5715836 0 0 0
0 7. 70518'^  52 0 :
8 5 0 ■ 3
T-B.E CF 'O' : PROTEIN CONCENTRATION (MG.GRAM-1)
1 3 2 0 0 0
a~l..4:;4:.4:?4:J::4;»i-:4-?4:^-'i:?4:,>-:4::J.,,(:l.;j::4:..;;.4::4;a::4-:4:i-f-.4::4:-(;:i:;4::4::l-?4-^i;i:^:5(r:(::i.;4..4;:4;:4:.4;:4;.<:-(:^;<:r4:?4:?f."4;S"4:'‘ r4:?4N::4;:4:;4:»;;)i:.4:.4;:);^.4;,j:,l:;^:,4:>:.4:?i:-4^
S. 73514753 18.2904198 0 0 0
0 9. 55527229 0 0 0
0 0 0 0 0
TABLE OF T " : 3H URIDINE INCnORPORATION (DPM. MG-1 RNA)
2 3 1 0 0 0
-43308.5008 908902.096 0 0 0
0 952210.597 0 0 0
0 0 0 0 0
;+::»::4:*;):ri:?4;'4-rJ"4-.-4.’4:>4.t4:?4--4 t?4T:4"i-*4 x-*.4::4';4::4::4::4?X:*,)?:(::i.:{..;4?*T):*?4?.4::4:*:**:4y4r4 ?4 :t $:» ?4-M.-4.4."f:*:t"t 4"4::* :f:*?t' 4'*:4.:4:i4"4(*;4:4:**i:!(::M"t'4=':it"*'*:t:*+'^4:*'4;:;;
"BLE OF 'O': TOTAL TISSUE DNA.-'PROTEIN RATIO
2 3 1 0 0 0
-5. 49'20928E-03 .089535262 0 0 0
0 . 0950294713 0 0 0
6 0 0 0 0
•^•■|'4'.^:4.:4VJ:4.4 •^, i- yv 4' i -« 4 4 « 4 * 4 4 4 A ;l-‘i*4*4*;<-4*4-«*' 1**^;4'4'4- 4:^:4 y**» v*;.^*-*:y*4'y",4*v. ^ 4 4 :j;4 "*'y"i "*"i'4 4 4, i ••4; * *i'4;4;y'4**' A'4'4*4’'f;‘^;4;;'j*4;4-«i"!r^"l '*t
1 6 5
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•AELE "  TOTAL TIEELE RiATRjTEIN F ^ tq
^ ‘4  '4*'4 4  "^ '4*4  y  it* 4 4  4  y  * 4  *  4  *» >•- .' 4  4 r * r (  4"4: i * 4 :  4 4 * 4  4 ' 4 '4 * 4  4 * 4 ; 4 '4  l ’ '4‘> ' i  4 ' t4 '^ ‘)f-4.'!4 '4"^ !'4?4*4‘ '^ *y“ i “i * ^ * 4 '4 ‘4 'v * ' i ; ^ 4 * ' l * y * * | ‘ '>*v-4-
2 3 .1 0 ' 0 0
4 - 4  ■*:*»:!4:4'.4-.;* •;?* 4 " f 4  + : 4 4 r : ^ : 4 : : t  4  )i.4 .-t:fr+:r4:5^-4::< .‘; f ' 4 . * * 4  i  v  f  v  4 ' 4 ”.  i: '4 : - i-4 ” +:-4;!i 4:4 . : : t : 4 : 4 : 4 : ) r  4 :4 :4-4 . .r :K 4  •♦;H:
-<ï T5E70711E-03 . 0873053553 0 . 0  0
0 .052062102^  0 * 0  0
0 0 0 0 0
TABLE OF '-Q' : TOTAL TIEEUE PNA/WJfl RATIO
2 3 . 1  0 ? G
y \,*4- é 4.4-4y4r4;-, 4;4r4:4;4:4 ;4;4 4::4:v-4;’4*4;;4’>:>-.i; 4/«.4r-ir4-:i:4**4:4:4:.'f:4;’i:4'**;4*0:;j*vv;*.4:4*4‘-4r4’4:y:*J-4;4;4r>K:«-4 'i:*V>;>:‘*'yr4r4::*:**;ÿ‘4:4L4:?|:4"'4.74:4‘4’4;:*t4r‘A’‘‘ ‘*^‘4”4 '* - v,*;*-
-1 155-5651 3. 562:2839 0 0 0
0 4.7195245 0 0 0
0 0 0 0 G
4t4r*.4*4::' •i:y:4-4- i:'i:4*4r4’ 4 %; t: «y. -j -, 4-4y.:y :jr+T:4r:4'4:'^ '4;4:*4:'»::4: 4x4r'4:*:4::4"4 4:4
TABLE OF "O ' : TOT^ l TIEEBE RN^ -DNA-'-FO^ EIN RATIO
;*,>-4.. . : .. ••4- *;y;4:4: +:4;:4.:4::4:>:4rrt::i::f;4:4;r4;;4;4;’i i-**- : 4:Y t:4y4-4r4;y:4.-4.:4:4'4, ; •. ,♦••: . •• >ry"*:?4’:ir)i:?4:>-:4;;4::4:;J:;4:.f.:4:>};jJ;**.'*'.-4: * i;>f::4:v:;:-4;>::l:C”i;C. ir>i*'‘:y;'*r'A‘n*** -V'^' -'^ '>"4:
'* '^74 y:y:'4r4':44:y:?::4:)4:)4:>4:y:)jrt 4;yT:4'y"4:)i':*:y:y'4:'*:)4:4x4%)z4::4::4:y::4::4::4:'4::4;4::4:*y:W:y:'4:)':'^ ')*'4:)f:
-6 .63216699E-02 .124569573 8 0 0
0 .13160114 0 0 0
0 0 0 0 0
TABLE OF "0" ; CVj=LAE«JC URIDü.E tTJCLEOTIDE POOL (DPM UM-1 URIDINE tCJOL EOT IDES)
1 3 2 0 0 0
-62774.7024 55392.8555 0 0 0
6 122157.558 0 0 0
0 0 0 0 0
TAELE CF "S"': 3H ACETYLATION 21 DRV KVCCYTE H1 H10 H3 H2R+2B H4
3 4 5 2 1 0
.540406125 .90255784 1.55461904 4. 4602534 0
0 .262591711 1 01421291 3. 9199A7BB 0
0 0 .751621201 3.65725557 0
0 0 0 2.90563436 0
0 . 0 0 0 0
.•t.:4:‘- 4:'::N >.•■*■ * ••..-•;i‘->4;:4-4-;4::4;.4:4..4;;4:.4;:J.:4r:f•4;:f.*4-:f:4v.fi('î 4*>’ t 4'M '4S.-.*.'“ f  •' •■*"• - 4 * * ••■*' • "J *- 4:*;.4 y :4"4::*;:4::4BT:'4 f.rt-y y; j  y.:i !4;:4:.4::4':4: 4.4- 4:. • ji-
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TABLE OF 'O' : RCETVLATICN 21 DRY l.'ON-MYOCYTE Hi H18 K3 K2A+2B H4
2 4 i  5 3 e
3.7196757 6. 30294016 6.86484341 8 813^ 715 0
0 2.58416447 3.14616772 5.0947958 0
0 0 .562003248 2. 51063133 0
8 0 0 1 94862809 0
0 0 0 0 0
■ABLE C" 'O'; 34 ACETYLATION 50 DRY MYXVE HI mC 43 H2R+2B H4
4 2 3 5 1 0
. 91283-^84 ■ 8 25531^ 8 9 38451355 9. A/902426 0
0 7.34248302 9.47168178 S. 53:192^8 0
0 0 1.12919975 1.19270SA5 0
0 0 0 . 0 6 3 5 1 0 7 0 2  0
0 0 0 0 0
TABLE OF 'O': 3H fiiOETVLATICS' 58 DAY î.'Of-'-MYOCYTE HI H10 H3 H2R+2B H4
4 3 2 5 0
.071609376 .983^81^03 18.3698339 20.350491 0
0 . 831876027 IS. 2982254 20 2788826 0
0 0 17.4663494 19.4470066 0
0 0 0 1.98065721 6
0 0 0 0 0
"-BLE OF -3": 3H PCETY'LATICN 100DAY MY'OCVTE HI HIO H3 H2A+2B H4
4 2 5 1 3 0
1 96123233 5.1193513 ' 9 12047068 12.4520386 0
0 3.15810897 7.15922835 10.4907963 0
0 0 4.00111938 7,33268728 0
0 .0  0 3,33156-9 0
0 0 167' 0 0
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
T T  T -}U Z-^rri-n ûTTr,»r r\5V u*
y*** •*••*"*• y y "i* i 4 y-ir+ t'4-**y* ;iyi' i : 4 ' J  ;* 'f * 4: 4 ** *"* > :*••• 4'»"4'4
1 2 8 8 8 0
3 6 .0277SL1 0 0 * 0  0
8 8 0 8 0
TABLE Cf /Q/; MVOCS'TE VS NON-MYOCYTE 3H ACETYLATION 100 DAY H3
2 1 0 0 0 0
24 7:80]::::- 0 8 0 0
0 0 0 0 0
TABLE OF 'O ': mvoc'-tp v< NON-MVOCYTE 3H ACETYLATION 100 DAY H2A^ 2B
:ir(;:4;*:4:'‘:'4:*:*-4-’‘'?‘").-;4'.'i:-i’:4:?l:J-;-4:'i"(:-(-i:*-:i:it;?4:4-(?-i;?).-;4'H?*:'»:4;:4;J:?(:4;ri;+if.>t.:4:!):i;?4:4:*:4:i:»"4:»'^"»:'- :-4-?:?.4'-4S 4 4?4?4?4 4.4-4: ;:<;4-K:'4x4:4 4 4"t?4"4:4:X:4?4 4?4 -:?^'4'
1 2 0 0 0 0'
4:4:4:4 4:4 'i:4:.4::4:4::4:4:4:4:4r4 -' 4 4:4:4'4 4:» 4:4:4:'i -;:4 4:4:4-; i-4:4:44:'4-44:4-::4:4'4:'4:4:4:4::4:'4:4:4:4:4:4 -4::44:4:4:4:4:4"':4:4"44:4 4:4: 4-^ :4:4:4:4-4'»:4;:4:4'4 4:4:4'4:*4:
6.70555907 0 0 8 0
0 0 0 0 8
:4:4 4:4 4:4:4:4:4:4:4:'4:4'4 4:-; 4:44:4-.4:4 4 -; 4 4-'::44 4:4::44:4:4:4'4:4'44:4:-;:4:4:4:4:4:4:4:4:4:4:4:4:4:4;4:4:44:4:4::;:4:4:4:4=|:4:4:4:4:4:4:4:44:4::M:4'*4'4:4'.4:4-':4:4:4::4:4:4:4:4:4:
TABLE Cf 'O' : MYOCYTE VS NON-lfYOCYTE 3H ACETYLATION 100 DAY H4
4nt.4:4:4:4:'4::4:'4:4:4:4 4:4:4:4:4:4:4:4:4:4:4:4:4:4::44:4:4:4:4:4:4:4:4:4:4::4:4:4:4::»:4:4:4:4:4'4::t4'4:4:4:44:4:4:4:4::4:4:4:4:4:4:45|:4:4:';:4:4 :! 4 4:4:4:4:4:4:4::4:t:4:4:4:4:4:4:4:4:4-4:4: 
1 2 0 0 0 0
;4z4:4:4:4:4:4:4:4::44::+:4:4:4:4:*4::4:4:4:4:4:4:4:4 :44:4:4:4:4:4:4:4:4:44:4:4:4:4:4:4:4::4:44::4:4"4:44:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:4:''::44 44:4:4:*4:4:4:4: 44::44:
.465282715 0 0 0 0
0 ■:• 0 0 0
.4-»-:‘.4-f:4'.:4r4.4;4-.4"4'.4’.4:;4:4'.4'.4:*:4:4:4:4:4r4:4-V4:4:;4:-*;-4:';:4:;-t:*4:t:4-4;4:4:*4:4:4:';:4:'4:4:4:4:4:4"*:4:4:4:*"*.4’4:4:';:4:4:-4'4':!:4:V4:4:4:>.4:-‘:.4:4;-;:4:4:4-:4:4:4=*:*'4:4:4:4:'4:4:4:
‘:4-;-*-4-4:.-J:.i. .. :■; ;.. • ... r-. 4 4 4:4:-;-4 * -. 4-4 4:4:4:4:4:4:4:4:4:4:4:-'.4:#'4:,r;.-,:-.:4:4:-; '•'‘:-;:'i:-*:-;-)-f‘ -':4:4:4:4-4:4:»:>‘:-*:>:t:4:4:
1 2 4 5 2 0
4.^;4S:4";:4:+4:4-:':4:4:4:4:4::4:4:4:4.-4:4:4:4::«:4:4:4:4:4:4:f:4'4:4::4:4:4::4:4:4:4:.4 4:4:4:4 4:4:4:4n4:4:4:W:4:4:4::4:4:4:|:4:4:4:4:4:4::4:4:4:4:.4:4:4.4:4:4:4:4:4:4:4:4:4:4.-4:4:.4:.4::44-(:4:4: 
.0169950262 692874146 5. 35212595 13. 7725878 0
G .67587912 5. 33513093 13.7555128 0
0 0 4.65925181 13.0796336 0
2 0 0 8.42038185 0
0 0 0 0 0
4'4:4-4'4:4-:4:'4"t-4-'^'4:4.:4:4:4:4:4:'*:4:4:'< 4-4-4 4-:4:4:4:4 :*-.4:4:t:4:4:4:4:4:4:4:4:.4:.V4"4:4.-‘:4:4:4:4-4:>M:*:4:4-4:4-:'-4:-4:4:4-4.-4-4-4-:*;4-4:-»:4:-4.-4:4:4-:4-4:;»:4:4:4:4:;4:4'4:4-4:4-4:4:-*:4:
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u:- "O': MYOCYTE VS NON-MYCCYTE 2M ACETYIATIOI: 21 DRY HI
2 1 0 • e 0 0
2 52??F?54 0 0 0 0
0 0 0 6 0
.4:4:.4:4r4-4:4:4-4r4-'4:**4:+'4:4''':4'4:4:-1?4:*4'4~':'(:i:H:4-'4-'4:4'4:4:4:4;:):4:4af:4:t+4;*4:.'‘"t:4:4:4:4:4-'4:4:*4:4:!t::f:i(-4-rt:4:4:.4:4::f:'t;4r4t4:4.-4-t4;4:4:4;4;.'):4a|:4:4;4:4:-»;'(-4:+4:4:1:
TABLE OF 'O': MYOCYTE VS HOti-MYOCVTE 2H ACETYLATION 21 DAY H2
4:4:* » 4  4:44:4.4 *4:*44:**4;4:4.'4:4'4:4:4"W:4.4?4:4:***:4'4'4:4:4*4:4:4:#:4?4r4:4Tt';: ;-4:4'; 4:4:4;*4:4'.4'4:4 4;4:4S:4:*4:'k4:**4:4:4 '; ';:4:4 44S:4:4:4:*4.4:4:4'4 * 4 :  
1 2 0 0 0 0
72957106S 0 0 0 0
0 •; 0 .0 0
TABLE OF '?': -TYOOY^E VS NON-WTVTE 3H PCSTVLAT" ; 21 Dpv H2P+2B
2 1 0 0 0 0
10. S446735 0 0 0 0
0 0 0 0 0
TABLE OF 'O' : WOCYTE '"S NON-MYOCYTE 3H ACETYLATION 21 DAY H4
4-;:.:4 :'::44:4:4:4:4:4:44:4:4:4:4:4:4::44:4:4:4:4:4:4:4:4:i:4:4:4:4:4:4::44r4:4:.4::44rk.4:4;4:4:4:4:4:4:4:4r4r;:'"4-:4-; 44:.4:4:4::f:4:4:4r.4::44:4:4:4:4'4'4'44:4?';:4:4:4:4:4:4:4rf:4:4:4'4: 
2 1 0 0 0 0
. 3A7135S76 0 0 0 0
0 0 0 0 0
y-N 'Y
TABLE OF 'O': MVOCVTE VS NON-MVOCVTE 3H ACETYLATION 50 DAYS HI
4:4;;:4:;:4r{:?^ ':':*:M:4:4:4.'*4:.?,-;:4.4:4.4::^ :4;4:4:4,.4:4;44;j:y::ÿ4:4.4:4;4:4;:^ 4:,l:4:44:4!:j:4:4:4:X:4:t44:4:4;4:4:4::jr4:4.4:4:4.4:4:4:4:4:4'4 4:4 4:4:4:4:44»:43t:4:W4:4"t**4:4:4: 
2 1 0 0 0 0
4:4:4 4:4:*4"f:-: ':*:''''^ :+*4 ;:4:4:4::i::4.:(::i::i::4:4:4':<:4::l:4'4::':4 4:4:44 :i-4::*:4:4::):.4::i:4 4:4:4:4:.4r*:4-;:4-4:4: lT:{:4:4.4::(:4:4:4:4:4-M:*4'.4:4:4:4:4:4y:4'4:4'4:4:43(:4:*4rf:4:4:4S'
4. 26173154 0 8 0 0
0 0 0 0 0
:4:4 4 4-4 4:«.4.4:4:'^:4:;-4 4:4:4 Y:4:.{:.:4.y:.;:).:^:{:i:4:4.:^:.j:;:;:4-4:4;4 4:4:'4;4:4:4:4;4:j:4:4:4:4:4:4:^:4.*4r4:4:4;.4:4.(.:{:y.»:;:*:{:,.);4,.4:|;:^:4:;:4:;r'4-4:4:f:4:4:4:4:4'4:4:4:4:4:4:4:f:
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TABLE OF 'O ' • MYOTYTE YS NON-MVCCYTE j:H AOETSIATION HIO
1 2 0 8 0 0 
4 r 4 * >  •4 *y :y :y :4 :4 t4 * '> f*4 :4 *4 ;4 ‘ 4 T 4 *4 :4 't* *4 :4 ''^ M f-4 ‘ 4 : 4 -^ -  i : 4 - 4 : 4 : 4 ; 4  4 r 4 i t : 4 r 4 n 4 : * 4 : 7 ^ 4 :4 :4 " 4 : 4 : : T : 'W '4  i  " '4  4 4  4 -4 ;> i:4 -
21 4Ç05B31 0 0 ' 8 0
0 0 0 0 0
TABlE OF 'Q': MYOCYTE YS NON-MYOCYTE 3K ACETYLATION 50 DAY H3
2 1 0 0 0 0
5. 83599573 0 0 0 0
0 0 0 0 0
)4:4:4:4:4 4r4'4T4:4S'4:'4:4:4:H:4:4:r4:4:4:4:4:4:4.:4:4:4:4:4-4:4:4::ir4'4:4:4;*4:'^:4:4:4 4:4:4:4'4':4:4:M 4M+r4:4;4*:4;4:4;4;y:y.';4:4:4;:4r4r:4y4r4:4:4:4:4:y'4:4:'4:4:4:4vl:4r*:^
TABLE OF 'O' • MYOCYTE VS NON-MYOCYTE 2H ACETMATION 50 DAY H2Ar2B
1 2 8 0 0 8'
4 :4 ::4 '4 r iT 4  4 y 4 : 4 T 4 T 4 : y : 4 :4 T 4 : 4 T 4 :4 : * 4 : 4 : :W : 4 '4 :4 : * * 4 : 4 n * : 4 : 4 ' :^ M 4 : 4 ' ' ' '  ^ > ^ M 4 '4 :4 :4 ''i - '' '4 :y '4 T T ^ :4 ;4 :4 ;4 :4 '4 '4 ;4  4 : 4 ;4 ;4 ; 4 : 4 : ^
7.42177445 8 0 0 8
0 0 0 0 0
TABLE OF 'Q ': MYOCYTE VS NON-MYOCYTE 3H ACETYLATION 50 DAY H4
1 2 0 0 0 0
2.9156345 0 0 0 0
0 0 0 0 0
TABLE OF 'O' : MYOCYTE VS NON-MYOiC'YTE 3H ACETYLATION 100 DAY Hi
2 1 0 0 0 0
13.3460409 0 0 0 0
8 0 0 0 8
170
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TABLE OF 'O': MVOOVTE ACETYLATION Kl. 21 50 108 DAYS
1 3 2 0 0 0
0. 85141541 11 3783086 0 0 0
0 2.52699323 0 0 0
0 0 0 6 0
TABLE OF 'O'; MYOCYTE 3H ACETYLATION H10 21 50 100 DAYS
2 1 3 0 0 0
. 599441954 2 17922127 0 0 6
0 1. 57977932 0 0 8
0 0 0 0 0
TABLE OF 'G-' ; MYOCYTE 3H ACETYLATION H3 21 50 160 DAYS
1 2 3 0 0 0
6.24384317 S. 47222191 0 0 6
6 2. 22837874 0 0 0
0 0 0 0 0
TABLE OF 'O'; M-'CC'-'TE 3K ACETYLATION K2P+2B 21 50 100 DAYS
1 3 2 0 0 0
-3.45720782 .724893415 0 0 0
0 4.18210624 0 0 0
0 0 0 0 0
TABLE OF 'O': MYOCYTE 3H ACETYLATION H4 21 50 100 DAYS
1 3 2 0 0 0
13 C93E323 27 5-':%:^ 0 0 0
0 14 4453061 6 6 0
0 0 0 0 0
. j '. *• * •. < .••'••*;> - .*r ■*•**:, ■*■ i i-, . 4 iyi 4 j;?* uy* * -i -i- * i--i > :'! V;:4:y::i 4'4' 4"y - *"4:,^ '^ "» "4 . 4*y ^  i y
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-:'LE C" I T : h  a c e t - l . m  21 lec drvs
*4 j - y  y * v  '  *  ;•■• i  " ." *"4' . "4;t i  ■* *" f . ' f :  Y - f :  * . - * " *  ' + * ' » . * / *  * 4 * • * - .  ,  4. .  .  *• 4;
: 2 3 0 0 0
2.90927323 3.4304185 0 . 0 0
0 .521140274 0 0 0
0 0 0 0 0
-FE.E C" : MT.'-MVOCYTE ]:H ACETYLATION HIO 21 50 100 DAY'S
1 3 2 0 0 0
22,7:46613 25.3558749 0 0 0
0 2.6012136 0 0 0
0 0 0 C 0
T-5LE OF 'Q' : NON-''*OCVTE 3H ACETYLAi''':'.' -3 21 50 100 DAY'S
V * :  j  :4r4*:* ;4r>. .4"*:'4' - 4 - 4  +;y.)*:.4::4%^:'4y4::4:Ÿ 4 ; 4 . •• •  . . '• '• y * " .  f
1 3 2 0 0 0
r-:*. i:i:4:4:ri\'-:^:4:4:4:4 4:4:4:4:4:)f:H:4:4:4'4,'.' *:'4 !:y::':4x4'y:y:y:y:>:4S:4:4:47'^:4:;4:4.4:;t:'*.:4:1:x:f <:+y:4:'4:T4:4:N:t:M:4
1 32553748 4. 2S38S747 0 0 0
0 2. S5838SS9 0 0 8
0 0 0 C 0
TABLE OF O': NON-MYOCYTE 3H ACETYLATION H2A+2B 21 50 100 DAYS
1 2 3 0 0 0
5.90973042 9.81843959 0 0 8
0 3.10870918 8 0 0
0 0 0 8 0
TABLE OF -'O': NON-MYOCYTE 3H ACETYLATION H4 21 50 100 DAYS
1 3 2 0 0 0
4.0067022 11 874096 0 0 0
0 7.86739383 0 8 . 0
0 0 8 0 - 0
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